Constellation Brands (STZ) 10-Q 30 Jun 22 2023 Q1 Quarterly report Financial data

Cover Page

Cover Page - shares	3 Months Ended
	May 31, 2022	Jun. 24, 2022
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	May 31, 2022
Document Transition Report	false
Entity File Number	001-08495
Entity Registrant Name	CONSTELLATION BRANDS, INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	16-0716709
Entity Address, Address Line One	207 High Point Drive
Entity Address, Address Line Two	Building 100
Entity Address, City or Town	Victor
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	14564
City Area Code	585
Local Phone Number	678-7100
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Central Index Key	0000016918
Amendment Flag	false
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q1
Current Fiscal Year End Date	--02-28
Class A Stock
Title of 12(b) Security	Class A Common Stock
Trading Symbol	STZ
Security Exchange Name	NYSE
Entity Common Stock, Shares Outstanding		159,330,225
Class B Stock
Title of 12(b) Security	Class B Common Stock
Trading Symbol	STZ.B
Security Exchange Name	NYSE
Entity Common Stock, Shares Outstanding		23,205,885
Class 1 Common Stock
Entity Common Stock, Shares Outstanding		2,248,714

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Millions	May 31, 2022	Feb. 28, 2022
Current assets:
Cash and cash equivalents	$ 101.8	$ 199.4
Accounts receivable	879.9	899
Inventories	1,656.4	1,573.2
Prepaid expenses and other	664.1	658.1
Total current assets	3,302.2	3,329.7
Property, plant, and equipment	6,163.3	6,059.6
Goodwill	7,915.1	7,862.4
Intangible assets	2,765.7	2,755.2
Equity method investments	2,534	2,688.7
Securities measured at fair value	172.3	191.4
Deferred income taxes	2,334.8	2,351.5
Other assets	653.7	617.3
Total assets	25,841.1	25,855.8
Current liabilities:
Short-term borrowings	124	323
Current maturities of long-term debt	575.1	605.3
Accounts payable	874.6	899.2
Other accrued expenses and liabilities	792.1	871.3
Total current liabilities	2,365.8	2,698.8
Long-term debt, less current maturities	10,278.2	9,488.2
Deferred income taxes and other liabilities	1,638.6	1,621
Total liabilities	14,282.6	13,808
Commitments and contingencies
CBI stockholders’ equity:
Additional paid-in capital	1,825	1,808.9
Retained earnings	14,746.2	14,505.4
Accumulated other comprehensive income (loss)	(166.3)	(412.7)
Total stockholders’ equity before treasury stock adjustments	16,407.1	15,903.8
Less: Treasury stock –	(5,175.7)	(4,171.9)
Total CBI stockholders’ equity	11,231.4	11,731.9
Noncontrolling interests	327.1	315.9
Total stockholders’ equity	11,558.5	12,047.8
Total liabilities and stockholders’ equity	25,841.1	25,855.8
Class A Stock
CBI stockholders’ equity:
Common stock, value	1.9	1.9
Less: Treasury stock –	(5,173.5)	(4,169.7)
Class B Stock
CBI stockholders’ equity:
Common stock, value	0.3	0.3
Less: Treasury stock –	$ (2.2)	$ (2.2)

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - $ / shares	May 31, 2022	Feb. 28, 2022
Class A Stock
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	322,000,000	322,000,000
Common stock, shares issued (in shares)	187,264,514	187,263,859
Treasury stock, at cost (in shares)	26,694,497	22,824,607
Class B Stock
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	30,000,000	30,000,000
Common stock, shares issued (in shares)	28,211,685	28,212,340
Treasury stock, at cost (in shares)	5,005,800	5,005,800

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income (Loss) - USD ($) shares in Thousands, $ in Millions	3 Months Ended
	May 31, 2022	May 31, 2021
Sales	$ 2,540.7	$ 2,188.3
Excise taxes	(177.5)	(161.8)
Net sales	2,363.2	2,026.5
Cost of product sold	(1,108.2)	(907.2)
Gross profit	1,255	1,119.3
Selling, general, and administrative expenses	(438.6)	(378.3)
Impairment of brewery construction in progress	0	(665.9)
Operating income (loss)	816.4	75.1
Income (loss) from unconsolidated investments	(187.9)	(899.2)
Interest expense	(88.5)	(86.7)
Loss on extinguishment of debt	(15.3)	0
Income (loss) before income taxes	524.7	(910.8)
(Provision for) benefit from income taxes	(125.4)	13.5
Net income (loss)	399.3	(897.3)
Net (income) loss attributable to noncontrolling interests	(9.8)	(10.8)
Net income (loss) attributable to CBI	389.5	(908.1)
Comprehensive income (loss)	658.3	(792.8)
Comprehensive (income) loss attributable to noncontrolling interests	(22.4)	(16.4)
Comprehensive income (loss) attributable to CBI	635.9	(809.2)
Class A Stock
Net income (loss) attributable to CBI	$ 345.6	$ (807.8)
Net income (loss) per common share attributable to CBI:
Net income (loss) per common share attributable to CBI - basic (in dollars per share)	$ 2.09	$ (4.74)
Net income (loss) per common share attributable to CBI - diluted (in dollars per share)	$ 2.06	$ (4.74)
Weighted average common shares outstanding:
Weighted average common shares outstanding - basic (in shares)	165,335	170,602
Weighted average common shares outstanding - diluted (in shares)	189,333	170,602
Cash dividends declared per common share:
Cash dividends declared per common share (in dollars per share)	$ 0.80	$ 0.76
Class B Stock
Net income (loss) attributable to CBI	$ 43.9	$ (100.3)
Net income (loss) per common share attributable to CBI:
Net income (loss) per common share attributable to CBI - basic (in dollars per share)	$ 1.89	$ (4.31)
Net income (loss) per common share attributable to CBI - diluted (in dollars per share)	$ 1.89	$ (4.31)
Weighted average common shares outstanding:
Weighted average common shares outstanding - basic (in shares)	23,206	23,247
Weighted average common shares outstanding - diluted (in shares)	23,206	23,247
Cash dividends declared per common share:
Cash dividends declared per common share (in dollars per share)	$ 0.72	$ 0.69

Consolidated Statements of Chan

Consolidated Statements of Changes in Stockholders' Equity - USD ($) $ in Millions	Total	Common Stock Class A Stock	Common Stock Class B Stock	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Income (Loss)	Treasury Stock	Noncontrolling Interests
Stockholders' equity, beginning of period at Feb. 28, 2021	$ 13,929.1	$ 1.9	$ 0.3	$ 1,604.2	$ 15,117.8	$ (335.5)	$ (2,789.8)	$ 330.2
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(897.3)				(908.1)			10.8
Other comprehensive income (loss), net of income tax effect	104.5					98.9		5.6
Comprehensive income (loss)	(792.8)
Repurchase of shares	(400.8)						(400.8)
Dividends declared	(146.1)				(146.1)
Noncontrolling interest distributions	(10.6)							(10.6)
Shares issued under equity compensation plans	2.9			(0.9)			3.8
Stock-based compensation	15.9			15.9
Stockholders' equity, end of period at May. 31, 2021	12,597.6	1.9	0.3	1,619.2	14,063.6	(236.6)	(3,186.8)	336
Stockholders' equity, beginning of period at Feb. 28, 2022	12,047.8	1.9	0.3	1,808.9	14,505.4	(412.7)	(4,171.9)	315.9
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	399.3				389.5			9.8
Other comprehensive income (loss), net of income tax effect	259					246.4		12.6
Comprehensive income (loss)	658.3
Repurchase of shares	(1,007.6)						(1,007.6)
Dividends declared	(148.7)				(148.7)
Noncontrolling interest distributions	(11.2)							(11.2)
Shares issued under equity compensation plans	3.2			(0.6)			3.8
Stock-based compensation	16.7			16.7
Stockholders' equity, end of period at May. 31, 2022	$ 11,558.5	$ 1.9	$ 0.3	$ 1,825	$ 14,746.2	$ (166.3)	$ (5,175.7)	$ 327.1

Consolidated Statements of Cash

Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Millions	3 Months Ended
	May 31, 2022	May 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss)	$ 399.3	$ (897.3)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Unrealized net (gain) loss on securities measured at fair value	22.4	745.1
Deferred tax provision (benefit)	21.5	(98.7)
Depreciation	92.7	76
Stock-based compensation	16.8	16
Equity in (earnings) losses of equity method investees and related activities, net of distributed earnings	165.5	154.1
Noncash lease expense	21.6	19.7
Amortization of debt issuance costs and loss on extinguishment of debt	17.7	2.7
Impairment of brewery construction in progress	0	665.9
Gain (loss) on settlement of Pre-issuance hedge contracts	20.7	0
Change in operating assets and liabilities, net of effects from purchase and sale of business:
Accounts receivable	17.2	(136.7)
Inventories	(83)	(82.3)
Prepaid expenses and other current assets	93.7	(11.7)
Accounts payable	94.5	224.1
Deferred revenue	26.2	130.5
Other accrued expenses and liabilities	(166.2)	(61.7)
Other	(2.4)	(29.7)
Total adjustments	358.9	1,613.3
Net cash provided by (used in) operating activities	758.2	716
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property, plant, and equipment	(196.6)	(113.9)
Purchase of business, net of cash acquired	(37.2)	0
Investments in equity method investees and securities	0	(8.5)
Proceeds from sale of assets	6.5	0.8
Proceeds from sale of business	0	5
Other investing activities	0.5	0
Net cash provided by (used in) investing activities	(226.8)	(116.6)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from issuance of long-term debt	1,846.8	6.3
Principal payments of long-term debt	(1,084.7)	(7.4)
Net proceeds from (repayments of) short-term borrowings	(199)	0
Dividends paid	(149.3)	(146.7)
Purchases of treasury stock	(1,007.6)	(400.8)
Proceeds from shares issued under equity compensation plans	14	12.5
Payments of minimum tax withholdings on stock-based payment awards	(10.4)	(9.8)
Payments of debt issuance, debt extinguishment, and other financing costs	(25.8)	0
Distributions to noncontrolling interests	(11.2)	(10.6)
Net cash provided by (used in) financing activities	(627.2)	(556.5)
Effect of exchange rate changes on cash and cash equivalents	(1.8)	0.3
Net increase (decrease) in cash and cash equivalents	(97.6)	43.2
Cash and cash equivalents, beginning of period	199.4	460.6
Cash and cash equivalents, end of period	101.8	503.8
Supplemental disclosures of noncash investing and financing activities
Additions to property, plant, and equipment	$ 83.1	$ 179.6

Basis of Presentation

Basis of Presentation	3 Months Ended
	May 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
BASIS OF PRESENTATION	BASIS OF PRESENTATIONWe have prepared the Financial Statements, without audit, pursuant to the rules and regulations of the SEC applicable to quarterly reporting on Form 10-Q and reflect, in our opinion, all adjustments necessary to present fairly our financial information. All such adjustments are of a normal recurring nature. Certain information and footnote disclosures normally included in financial statements, prepared in accordance with generally accepted accounting principles, have been condensed or omitted as permitted by such rules and regulations. These Financial Statements should be read in conjunction with the consolidated financial statements and related notes included in the 2022 Annual Report. Results of operations for interim periods are not necessarily indicative of annual results.

Inventories

Inventories	3 Months Ended
	May 31, 2022
Inventory Disclosure [Abstract]
INVENTORIES	INVENTORIES Inventories are stated at the lower of cost (primarily computed in accordance with the first-in, first-out method) or net realizable value. Elements of cost include materials, labor, and overhead and consist of the following: May 31, February 28, (in millions) Raw materials and supplies $ 215.0 $ 185.3 In-process inventories 820.9 804.8 Finished case goods 620.5 583.1 $ 1,656.4 $ 1,573.2 We assess the valuation of our inventories and reduce the carrying value of those inventories that are obsolete or in excess of our forecasted usage to their estimated net realizable value based on analyses and assumptions including, but not limited to, historical usage, future demand, and market requirements. We evaluated the carrying value of certain inventories and recognized the following in cost of product sold within our consolidated results of operations: For the Three Months 2022 2021 (in millions) Loss on inventory write-down $ 6.1 $ 16.0

Derivative Instruments

Derivative Instruments	3 Months Ended
	May 31, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
DERIVATIVE INSTRUMENTS	DERIVATIVE INSTRUMENTS Overview Our risk management and derivative accounting policies are presented in Notes 1 and 6 of our consolidated financial statements included in our 2022 Annual Report and have not changed significantly for the three months ended May 31, 2022. We have an investment in certain equity securities and other rights which provide us with the option to purchase an additional ownership interest in the equity securities of Canopy (see Note 7). This investment is included in securities measured at fair value and is accounted for at fair value, with the net gain (loss) from the changes in fair value of this investment recognized in income (loss) from unconsolidated investments (see Note 4). The aggregate notional value of outstanding derivative instruments is as follows: May 31, February 28, (in millions) Derivative instruments designated as hedging instruments Foreign currency contracts $ 2,030.2 $ 1,863.2 Pre-issuance hedge contracts $ — $ 100.0 Derivative instruments not designated as hedging instruments Foreign currency contracts $ 696.0 $ 497.6 Commodity derivative contracts $ 342.0 $ 291.1 Credit risk We are exposed to credit-related losses if the counterparties to our derivative contracts default. This credit risk is limited to the fair value of the derivative contracts. To manage this risk, we contract only with major financial institutions that have earned investment-grade credit ratings and with whom we have standard International Swaps and Derivatives Association agreements which allow for net settlement of the derivative contracts. We have also established counterparty credit guidelines that are regularly monitored. Because of these safeguards, we believe the risk of loss from counterparty default to be immaterial. In addition, our derivative instruments are not subject to credit rating contingencies or collateral requirements. As of May 31, 2022, the estimated fair value of derivative instruments in a net liability position due to counterparties was $3.9 million. If we were required to settle the net liability position under these derivative instruments on May 31, 2022, we would have had sufficient available liquidity on hand to satisfy this obligation. Results of period derivative activity The estimated fair value and location of our derivative instruments on our balance sheets are as follows (see Note 4): Assets Liabilities May 31, February 28, May 31, February 28, (in millions) Derivative instruments designated as hedging instruments Foreign currency contracts: Prepaid expenses and other $ 61.9 $ 28.6 Other accrued expenses and liabilities $ 10.1 $ 5.9 Other assets $ 72.2 $ 25.1 Deferred income taxes and other liabilities $ 7.6 $ 8.6 Pre-issuance hedge contracts: Other assets $ — $ — Deferred income taxes and other liabilities $ — $ 0.4 Derivative instruments not designated as hedging instruments Foreign currency contracts: Prepaid expenses and other $ 13.7 $ 2.7 Other accrued expenses and liabilities $ 4.8 $ 3.3 Commodity derivative contracts: Prepaid expenses and other $ 92.3 $ 61.3 Other accrued expenses and liabilities $ 5.4 $ 0.7 Other assets $ 28.5 $ 29.7 Deferred income taxes and other liabilities $ 2.6 $ 0.2 The principal effect of our derivative instruments designated in cash flow hedging relationships on our results of operations, as well as OCI, net of income tax effect, is as follows: Derivative Instruments in Net Location of Net Gain (Loss) Net (in millions) For the Three Months Ended May 31, 2022 Foreign currency contracts $ 79.5 Sales $ (0.6) Cost of product sold 11.1 Pre-issuance hedge contracts 15.7 Interest expense (0.5) $ 95.2 $ 10.0 For the Three Months Ended May 31, 2021 Foreign currency contracts $ 19.3 Sales $ (0.2) Cost of product sold 9.0 Pre-issuance hedge contracts — Interest expense (0.6) $ 19.3 $ 8.2 We expect $45.6 million of net gains, net of income tax effect, to be reclassified from AOCI to our results of operations within the next 12 months. The effect of our undesignated derivative instruments on our results of operations is as follows: Derivative Instruments Not Location of Net Gain (Loss) Net (in millions) For the Three Months Ended May 31, 2022 Commodity derivative contracts Cost of product sold $ 48.5 Foreign currency contracts Selling, general, and administrative expenses 6.2 $ 54.7 For the Three Months Ended May 31, 2021 Commodity derivative contracts Cost of product sold $ 24.1 Foreign currency contracts Selling, general, and administrative expenses (2.2) $ 21.9

Fair Value of Financial Instrum

Fair Value of Financial Instruments	3 Months Ended
	May 31, 2022
Fair Value Disclosures [Abstract]
FAIR VALUE OF FINANCIAL INSTRUMENTS	FAIR VALUE OF FINANCIAL INSTRUMENTS Authoritative guidance establishes a framework for measuring fair value, including a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. The hierarchy includes three levels: • Level 1 inputs are quoted prices in active markets for identical assets or liabilities; • Level 2 inputs include data points that are observable such as quoted prices for similar assets or liabilities in active markets, quoted prices for identical assets or similar assets or liabilities in markets that are not active, and inputs (other than quoted prices) such as volatility, interest rates, and yield curves that are observable for the asset and liability, either directly or indirectly; and • Level 3 inputs are unobservable data points for the asset or liability, and include situations where there is little, if any, market activity for the asset or liability. Fair value methodology The following methods and assumptions are used to estimate the fair value for each class of our financial instruments: Foreign currency and commodity derivative contracts The fair value is estimated using market-based inputs, obtained from independent pricing services, entered into valuation models. These valuation models require various inputs, including contractual terms, market foreign exchange prices, market commodity prices, interest-rate yield curves, and currency volatilities, as applicable (Level 2 fair value measurement). Interest rate swap and Pre-issuance hedge contracts The fair value is estimated based on quoted market prices from respective counterparties. Quotes are corroborated by using discounted cash flow calculations based upon forward interest-rate yield curves, which are obtained from independent pricing services (Level 2 fair value measurement). Canopy investment Equity securities, Warrants – The November 2018 Canopy Warrants consist of three tranches of warrants, including 88.5 million Tranche A Warrants expiring November 1, 2023, which are currently exercisable, 38.4 million Tranche B Warrants expiring November 1, 2026, and 12.8 million Tranche C Warrants expiring November 1, 2026. The inputs used to estimate the fair value of the November 2018 Canopy Warrants are as follows (1) (2) : May 31, 2022 February 28, 2022 Tranche A Warrants (3) Tranche B Warrants (4) Tranche A Warrants (3) Tranche B Warrants (4) Exercise price (5) C$ 50.40 C$ 76.68 C$ 50.40 C$ 76.68 Valuation date stock price (6) C$ 6.33 C$ 6.33 C$ 9.04 C$ 9.04 Remaining contractual term (7) 1.4 years 4.4 years 1.7 years 4.7 years Expected volatility (8) 85.0 % 85.0 % 75.0 % 75.0 % Risk-free interest rate (9) 2.6 % 2.7 % 1.4 % 1.7 % Expected dividend yield (10) 0.0 % 0.0 % 0.0 % 0.0 % (1) The exercise price for the Tranche C Warrants is based on the VWAP Exercise Price. The Tranche C Warrants are not included in the table as there is no fair value assigned. (2) In connection with the Acreage Transaction, we obtained other rights which include a share repurchase credit. If Canopy has not purchased the lesser of 27,378,866 Canopy common shares, or C$1,583.0 million worth of Canopy common shares for cancellation between April 18, 2019, and two-years after the full exercise of the Tranche A Warrants, we will be credited an amount that will reduce the aggregate exercise price otherwise payable upon each exercise of the Tranche B Warrants and Tranche C Warrants. The credit will be an amount equal to the difference between C$1,583.0 million and the actual price paid by Canopy in purchasing its common shares for cancellation. The likelihood of receiving the share repurchase credit if we were to fully exercise the Tranche A Warrants is remote, therefore, no fair value has been assigned. (3) The fair value is estimated using the Black-Scholes option-pricing model (Level 2 fair value measurement). (4) The fair value is estimated using Monte Carlo simulations (Level 2 fair value measurement). (5) Based on the exercise price from the applicable underlying agreements. (6) Based on the closing market price for Canopy common stock on the TSX as of the applicable date. (7) Based on the expiration date of the warrants. (8) Based on consideration of historical and/or implied volatility levels of the underlying equity security and limited consideration of historical peer group volatility levels. (9) Based on the implied yield currently available on Canadian Treasury zero coupon issues with a remaining term equal to the expiration date of the applicable warrants. (10) Based on historical dividend levels. Debt securities, Convertible – We have elected the fair value option to account for the Canopy Debt Securities acquired in June 2018 for C$200.0 million, or $150.5 million. Interest income on the Canopy Debt Securities is calculated using the effective interest method and is recognized separately from the changes in fair value in interest expense. The Canopy Debt Securities have a contractual maturity of five years from the date of issuance but may be converted prior to maturity by either party upon the occurrence of certain events. The fair value is estimated using a binomial lattice option-pricing model (Level 2 fair value measurement), which includes an estimate of the credit spread based on market spreads using bond data as of the valuation date. For additional information on the Canopy Debt Securities refer to Note 7. The inputs used to estimate the fair value of the Canopy Debt Securities are as follows: May 31, February 28, Conversion price (1) C$ 48.17 C$ 48.17 Valuation date stock price (2) C$ 6.33 C$ 9.04 Remaining term (3) 1.1 years 1.4 years Expected volatility (4) 85.0 % 75.0 % Risk-free interest rate (5) 2.5 % 1.4 % Expected dividend yield (6) 0.0 % 0.0 % (1) Based on the rate which the Canopy Debt Securities may be converted into equity shares, or the equivalent amount of cash, at the option of the issuer. (2) Based on the closing market price for Canopy common stock on the TSX as of the applicable date. (3) Based on the contractual maturity date of the notes. (4) Based on consideration of historical and/or implied volatility levels of the underlying equity security, adjusted for certain risks associated with debt securities, as appropriate. (5) Based on the implied yield currently available on Canadian Treasury zero coupon issues with a term equal to the remaining contractual term of the Canopy Debt Securities. (6) Based on historical dividend levels. Short-term borrowings Our short-term borrowings consist of our commercial paper program and the revolving credit facility under our senior credit facility. The revolving credit facility is a variable interest rate bearing note with a fixed margin, adjustable based upon our debt rating (as defined in our senior credit facility). For these short-term borrowings the carrying value approximates the fair value. Long-term debt The term loan under our term credit agreement is a variable interest rate bearing note with a fixed margin, adjustable based upon our debt rating. The carrying value approximates the fair value of the term loan. The fair value of the remaining fixed interest rate long-term debt is estimated by discounting cash flows using interest rates currently available for debt with similar terms and maturities (Level 2 fair value measurement). The carrying amounts of certain of our financial instruments, including cash and cash equivalents, accounts receivable, and accounts payable, approximate fair value as of May 31, 2022, and February 28, 2022, due to the relatively short maturity of these instruments. As of May 31, 2022, the carrying amount of long-term debt, including the current portion, was $10,853.3 million, compared with an estimated fair value of $10,442.9 million. As of February 28, 2022, the carrying amount of long-term debt, including the current portion, was $10,093.5 million, compared with an estimated fair value of $10,345.3 million. Recurring basis measurements The following table presents our financial assets and liabilities measured at estimated fair value on a recurring basis: Fair Value Measurements Using Quoted Significant Significant Total (in millions) May 31, 2022 Assets: Foreign currency contracts $ — $ 147.8 $ — $ 147.8 Commodity derivative contracts $ — $ 120.8 $ — $ 120.8 November 2018 Canopy Warrants (1) $ — $ 17.6 $ — $ 17.6 Canopy Debt Securities (1) $ — $ 146.1 $ — $ 146.1 Liabilities: Foreign currency contracts $ — $ 22.5 $ — $ 22.5 Commodity derivative contracts $ — $ 8.0 $ — $ 8.0 February 28, 2022 Assets: Foreign currency contracts $ — $ 56.4 $ — $ 56.4 Commodity derivative contracts $ — $ 91.0 $ — $ 91.0 November 2018 Canopy Warrants (1) $ — $ 36.3 $ — $ 36.3 Canopy Debt Securities (1) $ — $ 146.6 $ — $ 146.6 Liabilities: Foreign currency contracts $ — $ 17.8 $ — $ 17.8 Commodity derivative contracts $ — $ 0.9 $ — $ 0.9 Pre-issuance hedge contracts $ — $ 0.4 $ — $ 0.4 (1) Unrealized net gain (loss) from the changes in fair value of our securities measured at fair value recognized in income (loss) from unconsolidated investments, are as follows: For the Three Months 2022 2021 (in millions) November 2018 Canopy Warrants $ (18.7) $ (736.2) Canopy Debt Securities (3.7) (8.9) $ (22.4) $ (745.1) Nonrecurring basis measurements The following table presents our assets and liabilities measured at estimated fair value on a nonrecurring basis for which an impairment assessment was performed for the period presented: Fair Value Measurements Using Quoted Significant Significant Total Losses (in millions) For the Three Months Ended May 31, 2021 Long-lived assets $ — $ — $ 20.0 $ 665.9 Long-lived assets In April 2021, our Board of Directors authorized management to sell or abandon the Mexicali Brewery. Subsequently, management determined that we will be unable to use or repurpose certain assets at the Mexicali Brewery. Accordingly, for the first quarter of Fiscal 2022, long-lived assets with a carrying value of $685.9 million were written down to their estimated fair value of $20.0 million, resulting in an impairment of $665.9 million. This impairment was included in impairment of brewery construction in progress within our consolidated results of operations for the three months ended May 31, 2021. Our estimate of fair value was determined based on the expected salvage value of the assets. The Mexicali Brewery is a component of the Beer segment. We continue to work with government officials in Mexico to (i) determine next steps for our suspended Mexicali Brewery construction project, (ii) pursue various forms of recovery for capitalized costs and additional expenses incurred in establishing the brewery, however, there can be no assurance of any recoveries, and (iii) explore options to add further capacity at other locations in Mexico, including the construction of the Veracruz Brewery where there is ample water and we will have a skilled workforce to meet our long-term needs. In the medium-term, under normal operating conditions, we have ample capacity at the Nava and Obregon breweries to meet consumer needs based on current growth forecasts and current and planned production capabilities. Expansion, optimization, and/or construction activities continue at our current brewery locations under our Mexico Beer Projects to align with our anticipated future growth expectations.

Goodwill

Goodwill	3 Months Ended
	May 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
GOODWILL	GOODWILL The changes in the carrying amount of goodwill are as follows: Beer Wine and Spirits Consolidated (in millions) Balance, February 28, 2021 $ 5,125.6 $ 2,667.9 $ 7,793.5 Purchase accounting allocations (1) — 79.6 79.6 Foreign currency translation adjustments (4.9) (5.8) (10.7) Balance, February 28, 2022 5,120.7 2,741.7 7,862.4 Purchase accounting allocations (2) — 25.9 25.9 Foreign currency translation adjustments 30.1 (3.3) 26.8 Balance, May 31, 2022 $ 5,150.8 $ 2,764.3 $ 7,915.1 (1) Preliminary purchase accounting allocations associated with the acquisition of My Favorite Neighbor and purchase accounting allocations associated with the acquisition of Empathy Wines. (2) Preliminary purchase accounting allocations associated with the acquisitions of My Favorite Neighbor, Lingua Franca, and Austin Cocktails. Acquisitions Austin Cocktails In April 2022, we acquired the remaining 73% ownership interest in Austin Cocktails, which included a portfolio of small batch, RTD cocktails. This transaction primarily included the acquisition of goodwill and a trademark. In addition, the purchase price for Austin Cocktails includes an earn-out over five years based on performance. The results of operations of Austin Cocktails are reported in the Wine and Spirits segment and have been included in our consolidated results of operations from the date of acquisition. For additional information on this transaction refer to Note 13. Lingua Franca In March 2022, we acquired the Lingua Franca business, including a collection of Oregon-based luxury wines, a vineyard, and a production facility. This transaction also includes the acquisition of a trademark and inventory. In addition, the purchase price for Lingua Franca includes an earn-out over seven years based on performance. The results of operations of Lingua Franca are reported in the Wine and Spirits segment and have been included in our consolidated results of operations from the date of acquisition. My Favorite Neighbor In November 2021, we acquired the remaining 65% ownership interest in My Favorite Neighbor, a super-luxury, DTC focused wine business as well as certain wholesale distributed brands. This transaction primarily included the acquisition of goodwill, trademarks, inventory, and property, plant, and equipment. In addition, the My Favorite Neighbor transaction includes an earn-out over 10 years based on performance, with a 50% minimum guarantee due at the end of the earn-out period. The results of operations of My Favorite Neighbor are reported in the Wine and Spirits segment and have been included in our consolidated results of operations from the date of acquisition.

Intangible Assets

Intangible Assets	3 Months Ended
	May 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
INTANGIBLE ASSETS	INTANGIBLE ASSETS The major components of intangible assets are as follows: May 31, 2022 February 28, 2022 Gross Net Gross Net (in millions) Amortizable intangible assets Customer relationships $ 87.1 $ 20.7 $ 87.1 $ 21.7 Other 20.8 — 20.9 — Total $ 107.9 20.7 $ 108.0 21.7 Nonamortizable intangible assets Trademarks 2,745.0 2,733.5 Total intangible assets $ 2,765.7 $ 2,755.2 We did not incur costs to renew or extend the term of acquired intangible assets for the three months ended May 31, 2022, and May 31, 2021. Net carrying amount represents the gross carrying value net of accumulated amortization.

Equity Method Investments

Equity Method Investments	3 Months Ended
	May 31, 2022
Equity Method Investments and Joint Ventures [Abstract]
EQUITY METHOD INVESTMENTS	EQUITY METHOD INVESTMENTS Our equity method investments are as follows: May 31, 2022 February 28, 2022 Carrying Value Ownership Percentage Carrying Value Ownership Percentage (in millions) Canopy Equity Method Investment (1) (2) $ 2,353.5 36.1 % $ 2,503.5 36.1 % Other equity method investments 180.5 20%-50% 185.2 20%-50% $ 2,534.0 $ 2,688.7 (1) The fair value based on the closing price of the underlying equity security as of May 31, 2022, and February 28, 2022, was $711.9 million and $1,014.8 million, respectively. Refer to discussion below on other-than-temporary impairment considerations. (2) Includes the following: Common Shares Purchase Price (in millions) November 2017 Canopy Investment 18.9 $ 130.1 November 2018 Canopy Investment 104.5 2,740.3 May 2020 Canopy Investment 18.9 173.9 142.3 $ 3,044.3 Canopy Equity Method Investment We complement our beverage alcohol strategy with our investment in Canopy, a leading provider of medicinal and recreational cannabis products. Equity in earnings (losses) from the Canopy Equity Method Investment and related activities is determined by recording the effect of basis differences. Amounts included in our consolidated results of operations for each period are as follows: For the Three Months 2022 2021 (in millions) Equity in earnings (losses) from Canopy and related activities $ (165.0) $ (155.8) Canopy has various equity and convertible debt securities outstanding, including primarily equity awards granted to its employees, and options and warrants issued to various third parties, including our November 2018 Canopy Warrants, Canopy Debt Securities, and the Acreage Financial Instrument (a call option for Canopy to acquire 70% of the shares of Acreage at a fixed exchange ratio and 30% at a floating exchange ratio). As of May 31, 2022, the exercise and/or conversion of certain of these outstanding securities could have a significant effect on our share of Canopy’s reported earnings or losses and our ownership interest in Canopy. We have evaluated the Canopy Equity Method Investment as of May 31, 2022, and determined that there was not an other-than-temporary impairment. Our conclusion was based on several contributing factors, including: (i) the period of time for which the fair value has been less than the carrying value, (ii) an expectation that Canopy’s results will improve, (iii) an expectation that the Canopy stock price will recover in the near-term, and (iv) our ability and intent to hold the investment until that recovery. We will continue to review the Canopy Equity Method Investment for an other-than-temporary impairment. If Canopy’s stock price does not recover above our C$20.54 carrying value in the near-term, it may result in an impairment of our Canopy Equity Method Investment. There may also be a future impairment of our Canopy Equity Method Investment if our expectations about Canopy’s prospective results and cash flows decline, which could be influenced by a variety of factors including adverse market conditions or if Canopy records a significant impairment of goodwill or intangible or other long-lived assets, makes significant asset sales, or has changes in senior management. The following table presents summarized financial information for Canopy prepared in accordance with U.S. GAAP. We recognize our equity in earnings (losses) for Canopy on a two-month lag. Accordingly, we recognized our share of Canopy’s earnings (losses) for the periods January through March 2022 and January through March 2021 in our three months ended May 31, 2022, and May 31, 2021, results, respectively. The three months ended May 31, 2022, includes substantial costs designed to drive efficiency and accelerate Canopy’s path to profitability. The amounts shown represent 100% of Canopy’s reported results of operations for the respective periods. For the Three Months 2022 2021 (in millions) Net sales $ 88.2 $ 117.3 Gross profit (loss) $ (125.7) $ 7.7 Net income (loss) $ (456.8) $ (487.1) Net income (loss) attributable to Canopy $ (453.7) $ (552.9) Subsequent event Canopy Debt Securities On June 29, 2022, certain holders of Canopy Debt Securities agreed to sell C$255 million of their Canopy Debt Securities to Canopy at 99% of principal value in exchange for newly issued shares of Canopy common stock. As part of this transaction, we agreed to sell C$100 million of our Canopy Debt Securities in exchange for Canopy common shares. The number of common shares issuable will be based on the volume-weighted average trading price of Canopy's common shares on the Nasdaq for a 10-day trading period beginning on and including June 30, 2022, provided that the exchange price will not be less than $2.50 or more than $3.50. As a result of the exchange, we will receive between 30.7 million and 21.9 million Canopy common shares in July 2022. This sale is not expected to significantly change our Canopy ownership percentage and we will continue to hold C$100 million of our Canopy Debt Securities following this transaction. As part of this transaction, the Canopy Debt Securities were amended to remove Canopy’s right to settle the Canopy Debt Securities on conversion into Canopy equity shares. As a result, the Canopy Debt Securities may only be settled in cash.

Borrowings

Borrowings	3 Months Ended
	May 31, 2022
Debt Disclosure [Abstract]
BORROWINGS	BORROWINGS Borrowings consist of the following: May 31, 2022 February 28, Current Long-term Total Total (in millions) Short-term borrowings Commercial paper $ 124.0 $ 323.0 $ 124.0 $ 323.0 Long-term debt Term loan credit facilities $ — $ 300.0 $ 300.0 $ 300.0 Senior notes 567.4 9,965.7 10,533.1 9,773.6 Other 7.7 12.5 20.2 19.9 $ 575.1 $ 10,278.2 $ 10,853.3 $ 10,093.5 Bank facilities Senior credit facility In April 2022, the Company, CB International, the Administrative Agent, and certain other lenders entered into the 2022 Restatement Agreement that amended and restated our then-existing senior credit facility (as amended and restated by the 2022 Restatement Agreement, the 2022 Credit Agreement). The principal changes effected by the 2022 Restatement Agreement were: • The refinance and increase of the existing revolving credit facility from $2.0 billion to $2.25 billion and extension of its maturity to April 14, 2027; • The refinement of certain negative covenants; and • The replacement of LIBOR rates with rates based on term SOFR. Term credit agreement In April 2022, the Company, the Administrative Agent, and the Lender amended the June 2021 Term Credit Agreement (as amended, the 2022 Term Credit Agreement). The principal changes effected by the amendment were the refinement of certain negative covenants and replacement of LIBOR rates with rates based on term SOFR. As of May 31, 2022, aggregate credit facilities under the 2022 Credit Agreement and the 2022 Term Credit Agreement consist of the following: Amount Maturity (in millions) 2022 Credit Agreement Revolving credit facility (1) (2) $ 2,250.0 Apr 14, 2027 2022 Term Credit Agreement Five-Year Term Facility (1) (3) $ 491.3 Jun 28, 2024 (1) Contractual interest rate varies based on our debt rating (as defined in the respective agreement) and is a function of SOFR plus a margin and a credit spread adjustment, or the base rate plus a margin, or, in certain circumstances where SOFR cannot be adequately ascertained or available, an alternative benchmark rate plus a margin. (2) We and/or CB International are the borrower under the $2,250.0 million revolving credit facility. Includes a sub-facility for letters of credit of up to $200.0 million. (3) We are the borrower under the Five-Year Term Facility. As of May 31, 2022, information with respect to borrowings under the 2022 Credit Agreement and the 2022 Term Credit Agreement is as follows: Outstanding Interest SOFR Outstanding Remaining borrowing capacity (1) (in millions) 2022 Credit Agreement Revolving credit facility $ — — % — % $ 12.0 $ 2,114.0 2022 Term Credit Agreement Five-Year Term Facility $ 300.0 1.7 % 0.88 % (1) Net of outstanding revolving credit facility borrowings and outstanding letters of credit under the 2022 Credit Agreement and outstanding borrowings under our commercial paper program of $124.0 million (excluding unamortized discount) (see “Commercial paper program” below). We and our subsidiaries are subject to covenants that are contained in the 2022 Credit Agreement and the 2022 Term Credit Agreement, including those restricting the incurrence of additional subsidiary indebtedness, additional liens, mergers and consolidations, transactions with affiliates, and sale and leaseback transactions, in each case subject to numerous conditions, exceptions, and thresholds. The financial covenants are limited to a minimum interest coverage ratio and a maximum net leverage ratio. Commercial paper program We have a commercial paper program which provides for the issuance of up to an aggregate principal amount of $2.0 billion of commercial paper. Our commercial paper program is backed by unused commitments under our revolving credit facility under our 2022 Credit Agreement. Accordingly, outstanding borrowings under our commercial paper program reduce the amount available under our revolving credit facility. As of May 31, 2022, we had $124.0 million of outstanding borrowings, net of unamortized discount, under our commercial paper program with a weighted average annual interest rate of 1.3% and a weighted average remaining term of five days. Pre-issuance hedge contracts In connection with the May 2022 Senior Notes, we entered into Pre-issuance hedge contracts, which were designated as cash flow hedges. As a result of these agreements, we hedged the treasury rate volatility on $300.0 million of future debt issuances. In May 2022, we terminated and settled all outstanding Pre-issuance hedge contracts, and recognized an unrealized gain, net of income tax effect, of $15.3 million in AOCI within our consolidated balance sheets. The gain on Pre-issuance hedge contracts is being amortized over 10 years to interest expense within our consolidated results of operations. See “Senior notes” below. Senior notes In May 2022, we issued $1,850.0 million aggregate principal amount of senior notes. Proceeds from this offering, net of discount and debt issuance costs, were $1,837.5 million. The May 2022 Senior Notes consist of: Date of Redemption Principal Maturity Interest Payments Stated Redemption Date Stated Basis Points (in millions, except basis points) 3.60% Senior Notes (1) $ 550.0 May 2024 May/Nov (2) 15 4.35% Senior Notes (1) (3) $ 600.0 May 2027 May/Nov Apr 2027 25 4.75% Senior Notes (1) (3) $ 700.0 May 2032 May/Nov Feb 2032 30 (1) Senior unsecured obligations which rank equally in right of payment to all of our existing and future senior unsecured indebtedness. (2) Redeemable, in whole or in part, at our option at any time at a redemption price equal to 100% of the outstanding principal amount, plus accrued and unpaid interest and a make-whole payment based on the present value of the future payments at the applicable treasury rate plus the stated basis points. (3) Redeemable, in whole or in part, at our option at any time prior to the stated redemption date as defined in the indenture, at a redemption price equal to 100% of the outstanding principal amount, plus accrued and unpaid interest and a make-whole payment based on the present value of the future payments at the applicable treasury rate plus the stated basis points as defined in the indenture. On or after the stated redemption date, redeemable, in whole or in part, at our option at any time at a redemption price equal to 100% of the outstanding principal amount, plus accrued and unpaid interest. In February 2018, we issued $600.0 million aggregate principal amount of 3.20% senior notes due February 2023. In May 2013, we issued $1,050.0 million aggregate principal amount of 4.25% senior notes due May 2023. In May 2022, we used a portion of the proceeds from the May 2022 Senior Notes to complete a series of cash tender offers to purchase the 3.20% February 2018 Senior Notes and the 4.25% May 2013 Senior Notes validly tendered pursuant to the tender offers. We settled the tender offers with holders of approximately 67% and 65% of the total outstanding principal amount of the 3.20% February 2018 Senior Notes and the 4.25% May 2013 Senior Notes, respectively. Total cash consideration paid for these purchases was $1,096.0 million and the total carrying amount of the notes was $1,080.7 million, resulting in a loss on extinguishment of debt of $15.3 million (including an immaterial amount of fees and other costs associated with the tender offers), which is included within our consolidated results. In addition, we paid any accrued interest on the tendered notes up to, but not including the date of settlement. In June 2022, we redeemed the remaining $198.2 million and $369.8 million outstanding principal balance of the 3.20% February 2018 Senior Notes and the 4.25% May 2013 Senior Notes, respectively. Total cash consideration paid was $575.5 million, which included the remaining principal amount of the notes of $568.0 million and a make-whole premium of $7.5 million which will be included in loss on extinguishment of debt within our consolidated results. See “Debt payments” below. Debt payments As of May 31, 2022, the required principal repayments under long-term debt obligations (excluding unamortized debt issuance costs and unamortized discounts of $63.6 million and $21.3 million, respectively) for the remaining nine months of Fiscal 2023 and for each of the five succeeding fiscal years and thereafter are as follows: (in millions) Fiscal 2023 (1) $ 574.1 Fiscal 2024 7.0 Fiscal 2025 1,254.0 Fiscal 2026 902.1 Fiscal 2027 600.9 Fiscal 2028 1,800.0 Thereafter 5,800.1 $ 10,938.2 (1) Includes $568.0 million remaining principal amount of the 3.20% February 2018 Senior Notes and 4.25% May 2013 Senior Notes, fully redeemed in June 2022.

Income Taxes

Income Taxes	3 Months Ended
	May 31, 2022
Income Tax Disclosure [Abstract]
INCOME TAXES	INCOME TAXES Our effective tax rate for the three months ended May 31, 2022, and May 31, 2021, was 23.9% and 1.5%, respectively. For the three months ended May 31, 2022, our effective tax rate was higher than the federal statutory rate of 21% primarily due to valuation allowances on the unrealized net loss from changes in fair value of our investment in Canopy and Canopy equity in earnings (losses), partially offset by the benefit of lower effective tax rates applicable to our foreign businesses. For the three months ended May 31, 2021, our effective tax rate was lower than the federal statutory rate of 21% primarily due to (i) valuation allowances on the unrealized net loss from changes in fair value of our investment in Canopy and Canopy equity in earnings (losses) and (ii) the impact of the long-lived asset impairment of brewery construction in progress, partially offset by the benefit of lower effective tax rates applicable to our foreign businesses.

Stockholders' Equity

Stockholders' Equity	3 Months Ended
	May 31, 2022
Equity [Abstract]
STOCKHOLDERS' EQUITY	STOCKHOLDERS’ EQUITY Common stock The number of shares of common stock issued and treasury stock, and associated share activity, are as follows: Common Stock Treasury Stock Class A Class B Class 1 Class A Class B Balance at February 28, 2022 187,263,859 28,212,340 2,248,679 22,824,607 5,005,800 Share repurchases — — — 4,065,508 — Conversion of shares 655 (655) — — — Exercise of stock options — — 35 (108,228) — Vesting of restricted stock units (1) — — — (71,064) — Vesting of performance share units (1) — — — (16,326) — Balance at May 31, 2022 187,264,514 28,211,685 2,248,714 26,694,497 5,005,800 Balance at February 28, 2021 187,204,280 28,270,288 612,936 17,070,550 5,005,800 Share repurchases — — — 1,696,722 — Conversion of shares 43,441 (42,810) (631) — — Exercise of stock options — — 781 (116,058) — Vesting of restricted stock units (1) — — — (66,157) — Vesting of performance share units (1) — — — (7,934) — Balance at May 31, 2021 187,247,721 28,227,478 613,086 18,577,123 5,005,800 (1) Net of the following shares withheld to satisfy tax withholding requirements: For the Three 2022 Restricted Stock Units 37,308 Performance Share Units 4,919 2021 Restricted Stock Units 36,048 Performance Share Units 4,565 Stock repurchases In January 2018, our Board of Directors authorized the repurchase of up to $3.0 billion of our Class A Stock and Class B Stock, which was fully utilized during the three months ended May 31, 2022. Shares repurchased under the 2018 Authorization have become treasury shares. Additionally, in January 2021, our Board of Directors authorized the repurchase of up to $2.0 billion of our Class A Stock and Class B Stock. The Board of Directors did not specify a date upon which this authorization would expire. Shares repurchased under this authorization become treasury shares. For the three months ended May 31, 2022, we repurchased 2,254,536 shares of Class A Stock pursuant to the 2018 Authorization at an aggregate cost of $563.6 million through a combination of open market transactions and an ASR that was announced in April 2022 and 1,810,972 shares of Class A Stock pursuant to the 2021 Authorization at an aggregate cost of $444.1 million through open market transactions. Subsequent to May 31, 2022, we repurchased 1,240,495 shares of Class A Stock pursuant to the 2021 Authorization at an aggregate cost of $293.0 million through open market transactions. Beginning May 25, 2022, all repurchases were made pursuant to a Rule 10b5-1 trading plan. As of June 30, 2022, total shares repurchased under the 2018 Authorization and the 2021 Authorization are as follows: Class A Common Shares Repurchase Dollar Value Number of (in millions, except share data) 2018 Authorization $ 3,000.0 $ 3,000.0 13,331,156 2021 Authorization $ 2,000.0 $ 737.1 3,051,467 Subsequent event Reclassification Agreement On June 30, 2022, we announced the Reclassification. To effect the Reclassification, we will seek to effectuate the Charter Amendment. If the Reclassification is completed, upon the Effective Time, each share of Class B Stock issued and outstanding immediately prior to the Effective Time will be reclassified, exchanged, and converted into one share of Class A Stock and the right to receive $64.64 in cash, without interest. The closing of the Reclassification is subject to customary conditions, including: • approval of the Charter Amendment by the affirmative vote of the holders of (i) a majority of the voting power of the issued and outstanding shares of Class A Stock and Class B Stock entitled to vote thereon, voting together as a single class, (ii) a majority of the issued and outstanding shares of Class B Stock, and (iii) the affirmative vote of at least 50.3% of the issued and outstanding shares of Class A Stock not held by the Sands Stockholder Group, executive officers of the Company, or directors that hold Class B Stock; • the effectiveness of our registration statement on Form S-4 to be filed with the SEC in connection with the Reclassification; • approval by the NYSE of the listing of the shares of Class A Stock into which the Class B Stock will be reclassified, exchanged, and converted into, subject to official notice of issuance; and • the accuracy of the representations and warranties of each party (subject to specified materiality qualifiers) and compliance in all material respects by each party with its obligations under the Reclassification Agreement. The Reclassification Agreement contains customary representations, warranties, and covenants of each of the parties thereto for a transaction of this type.

Net Income (Loss) Per Common Sh

Net Income (Loss) Per Common Share Attributable to CBI	3 Months Ended
	May 31, 2022
Earnings Per Share [Abstract]
NET INCOME (LOSS) PER COMMON SHARE ATTRIBUTABLE TO CBI	NET INCOME (LOSS) PER COMMON SHARE ATTRIBUTABLE TO CBI For the three months ended May 31, 2022, net income (loss) per common share – diluted for Class A Stock has been computed using the if-converted method and assumes the exercise of stock options using the treasury stock method and the conversion of Class B Stock as this method is more dilutive than the two-class method. For the three months ended May 31, 2022, net income (loss) per common share – diluted for Class B Stock has been computed using the two-class method and does not assume conversion of Class B Stock into shares of Class A Stock. For the three months ended May 31, 2021, net income (loss) per common share – diluted for Class A Stock and Class B Stock have been computed using the two-class method. The computation of basic and diluted net income (loss) per common share is as follows: For the Three Months Ended May 31, 2022 May 31, 2021 Class A Stock Class B Stock Class A Stock Class B Stock (in millions, except per share data) Net income (loss) attributable to CBI allocated – basic $ 345.6 $ 43.9 $ (807.8) $ (100.3) Conversion of Class B common shares into Class A common shares 43.9 — — — Effect of stock-based awards on allocated net income (loss) — (0.1) — — Net income (loss) attributable to CBI allocated – diluted $ 389.5 $ 43.8 $ (807.8) $ (100.3) Weighted average common shares outstanding – basic 165.335 23.206 170.602 23.247 Conversion of Class B common shares into Class A common shares (1) 23.206 — — — Stock-based awards, primarily stock options (1) 0.792 — — — Weighted average common shares outstanding – diluted 189.333 23.206 170.602 23.247 Net income (loss) per common share attributable to CBI – $ 2.09 $ 1.89 $ (4.74) $ (4.31) Net income (loss) per common share attributable to CBI – $ 2.06 $ 1.89 $ (4.74) $ (4.31) (1) For the three months ended May 31, 2021, we have excluded the following weighted average common shares outstanding from the calculation of diluted net income (loss) per common share, as the effect of including these would have been anti-dilutive, in millions: Class B Stock 23.247 Stock-based awards, primarily stock options 2.034

Comprehensive Income (Loss) Att

Comprehensive Income (Loss) Attributable to CBI	3 Months Ended
	May 31, 2022
Equity [Abstract]
COMPREHENSIVE INCOME (LOSS) ATTRIBUTABLE TO CBI	COMPREHENSIVE INCOME (LOSS) ATTRIBUTABLE TO CBI Comprehensive income (loss) consists of net income (loss), foreign currency translation adjustments, unrealized net gain (loss) on derivative instruments, pension/postretirement adjustments, and our share of OCI of equity method investments. The reconciliation of net income (loss) attributable to CBI to comprehensive income (loss) attributable to CBI is as follows: Before Tax Tax (Expense) Net of Tax (in millions) For the Three Months Ended May 31, 2022 Net income (loss) attributable to CBI $ 389.5 Other comprehensive income (loss) attributable to CBI: Foreign currency translation adjustments: Net gain (loss) $ 170.3 $ — 170.3 Reclassification adjustments — — — Net gain (loss) recognized in other comprehensive income (loss) 170.3 — 170.3 Unrealized gain (loss) on cash flow hedges: Net derivative gain (loss) 105.5 (14.8) 90.7 Reclassification adjustments (10.0) 0.9 (9.1) Net gain (loss) recognized in other comprehensive income (loss) 95.5 (13.9) 81.6 Pension/postretirement adjustments: Net actuarial gain (loss) (0.3) — (0.3) Reclassification adjustments — — — Net gain (loss) recognized in other comprehensive income (loss) (0.3) — (0.3) Before Tax Tax (Expense) Net of Tax (in millions) Share of OCI of equity method investments Net gain (loss) (9.0) 3.8 (5.2) Reclassification adjustments — — — Net gain (loss) recognized in other comprehensive income (loss) (9.0) 3.8 (5.2) Other comprehensive income (loss) attributable to CBI $ 256.5 $ (10.1) 246.4 Comprehensive income (loss) attributable to CBI $ 635.9 For the Three Months Ended May 31, 2021 Net income (loss) attributable to CBI $ (908.1) Other comprehensive income (loss) attributable to CBI: Foreign currency translation adjustments: Net gain (loss) $ 103.0 $ — 103.0 Reclassification adjustments — — — Net gain (loss) recognized in other comprehensive income (loss) 103.0 — 103.0 Unrealized gain (loss) on cash flow hedges: Net derivative gain (loss) 27.5 (9.8) 17.7 Reclassification adjustments (7.8) 0.2 (7.6) Net gain (loss) recognized in other comprehensive income (loss) 19.7 (9.6) 10.1 Pension/postretirement adjustments: Net actuarial gain (loss) (0.2) — (0.2) Reclassification adjustments — — — Net gain (loss) recognized in other comprehensive income (loss) (0.2) — (0.2) Share of OCI of equity method investments Net gain (loss) (18.1) 4.1 (14.0) Reclassification adjustments — — — Net gain (loss) recognized in other comprehensive income (loss) (18.1) 4.1 (14.0) Other comprehensive income (loss) attributable to CBI $ 104.4 $ (5.5) 98.9 Comprehensive income (loss) attributable to CBI $ (809.2) AOCI, net of income tax effect, includes the following components: Foreign Unrealized Net Pension/ Share of OCI AOCI (in millions) Balance, February 28, 2022 $ (431.4) $ 17.5 $ (4.0) $ 5.2 $ (412.7) OCI: OCI before reclassification adjustments 170.3 90.7 (0.3) (5.2) 255.5 Amounts reclassified from AOCI — (9.1) — — (9.1) OCI 170.3 81.6 (0.3) (5.2) 246.4 Balance, May 31, 2022 $ (261.1) $ 99.1 $ (4.3) $ — $ (166.3)

Business Segment Information

Business Segment Information	3 Months Ended
	May 31, 2022
Segment Reporting [Abstract]
BUSINESS SEGMENT INFORMATION	BUSINESS SEGMENT INFORMATION Our internal management financial reporting consists of three business divisions: (i) Beer, (ii) Wine and Spirits, and (iii) Canopy and we report our operating results in four segments: (i) Beer, (ii) Wine and Spirits, (iii) Corporate Operations and Other, and (iv) Canopy. The Canopy Equity Method Investment makes up the Canopy segment. In the Beer segment, our portfolio consists of high-end imported beer brands, craft beer, and ABAs. We have an exclusive perpetual brand license to import, market, and sell our Mexican beer portfolio in the U.S. In the Wine and Spirits segment, we sell a portfolio that includes higher-margin, higher-growth wine brands complemented by certain higher-end spirits brands. Amounts included in the Corporate Operations and Other segment consist of costs of executive management, corporate development, corporate finance, corporate growth and strategy, human resources, internal audit, investor relations, legal, public relations, and information technology, as well as our investments made through our corporate venture capital function . All costs included in the Corporate Operations and Other segment are general costs that are applicable to the consolidated group and are, therefore, not allocated to the other reportable segments. All costs reported within the Corporate Operations and Other segment are not included in our CODM’s evaluation of the operating income (loss) performance of the other reportable segments. The business segments reflect how our operations are managed, how resources are allocated, how operating performance is evaluated by senior management, and the structure of our internal financial reporting. Long-lived tangible assets and total asset information by segment is not provided to, or reviewed by, our CODM as it is not used to make strategic decisions, allocate resources, or assess performance. In addition, management excludes Comparable Adjustments from its evaluation of the results of each operating segment as these Comparable Adjustments are not reflective of core operations of the segments. Segment operating performance and the incentive compensation of segment management are evaluated based on core segment operating income (loss) which does not include the impact of these Comparable Adjustments. We evaluate segment operating performance based on operating income (loss) of the respective business units. Comparable Adjustments that impacted comparability in our segment operating income (loss) for each period are as follows: For the Three Months 2022 2021 (in millions) Cost of product sold Net gain (loss) on undesignated commodity derivative contracts $ 48.5 $ 24.1 Recovery of inventory write-down 0.2 — Settlements of undesignated commodity derivative contracts (23.3) (3.4) Flow through of inventory step-up (1.0) — Strategic business development costs — (2.6) Total cost of product sold 24.4 18.1 Selling, general, and administrative expenses Transition services agreements activity (3.4) (2.3) Restructuring and other strategic business development costs (1.4) (0.9) Transaction, integration, and other acquisition-related costs (0.2) — Other gains (losses) (1) 4.5 3.3 Total selling, general, and administrative expenses (0.5) 0.1 Impairment of brewery construction in progress — (665.9) Comparable Adjustments, Operating income (loss) $ 23.9 $ (647.7) (1) The three months ended May 31, 2022, primarily includes a gain of $5.2 million related to the remeasurement of our previously held 27% equity interest in Austin Cocktails to the acquisition date fair value. The accounting policies of the segments are the same as those described for the Company in Note 1 of our consolidated financial statements included in our 2022 Annual Report. Amounts included below for the Canopy segment represent 100% of Canopy’s reported results on a two-month lag, prepared in accordance with U.S. GAAP , and converted from Canadian dollars to U.S. dollars. Although we own less than 100% of the outstanding shares of Canopy, 100% of its results are included in the information below and subsequently eliminated in order to reconcile to our consolidated financial statements . Segment information is as follows: For the Three Months 2022 2021 (in millions) Beer Net sales $ 1,898.2 $ 1,572.0 Segment operating income (loss) $ 762.8 $ 673.1 Capital expenditures $ 161.8 $ 85.8 Depreciation and amortization $ 68.2 $ 54.0 Wine and Spirits Net sales: Wine $ 404.1 $ 397.7 Spirits 60.9 56.8 Net sales $ 465.0 $ 454.5 Segment operating income (loss) $ 91.0 $ 104.2 Income (loss) from unconsolidated investments $ 1.5 $ 1.3 Equity method investments $ 98.0 $ 128.0 Capital expenditures $ 29.8 $ 25.7 Depreciation and amortization $ 22.3 $ 19.9 Corporate Operations and Other Segment operating income (loss) $ (61.3) $ (54.5) Income (loss) from unconsolidated investments $ (2.0) $ (0.6) Equity method investments $ 82.5 $ 91.9 Capital expenditures $ 5.0 $ 2.4 Depreciation and amortization $ 3.2 $ 3.3 Canopy Net sales $ 88.2 $ 117.3 Segment operating income (loss) $ (418.2) $ (184.2) Capital expenditures $ 0.1 $ 21.0 Depreciation and amortization $ 24.1 $ 22.9 Consolidation and Eliminations Net sales $ (88.2) $ (117.3) Operating income (loss) $ 418.2 $ 184.2 Income (loss) from unconsolidated investments $ (52.0) $ (44.3) Equity method investments $ 2,353.5 $ 2,436.8 Capital expenditures $ (0.1) $ (21.0) Depreciation and amortization $ (24.1) $ (22.9) For the Three Months 2022 2021 (in millions) Comparable Adjustments Operating income (loss) $ 23.9 $ (647.7) Income (loss) from unconsolidated investments $ (135.4) $ (855.6) Consolidated Net sales $ 2,363.2 $ 2,026.5 Operating income (loss) $ 816.4 $ 75.1 Income (loss) from unconsolidated investments (1) $ (187.9) $ (899.2) Equity method investments $ 2,534.0 $ 2,656.7 Capital expenditures $ 196.6 $ 113.9 Depreciation and amortization $ 93.7 $ 77.2 (1) Income (loss) from unconsolidated investments consists of: For the Three Months 2022 2021 (in millions) Unrealized net gain (loss) on securities measured at fair value $ (22.4) $ (745.1) Equity in earnings (losses) from Canopy and related activities (165.0) (155.8) Equity in earnings (losses) from other equity method investees (0.5) 1.7 $ (187.9) $ (899.2)

Basis of Presentation (Policies

Basis of Presentation (Policies)	3 Months Ended
	May 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of presentation	We have prepared the Financial Statements, without audit, pursuant to the rules and regulations of the SEC applicable to quarterly reporting on Form 10-Q and reflect, in our opinion, all adjustments necessary to present fairly our financial information. All such adjustments are of a normal recurring nature. Certain information and footnote disclosures normally included in financial statements, prepared in accordance with generally accepted accounting principles, have been condensed or omitted as permitted by such rules and regulations. These Financial Statements should be read in conjunction with the consolidated financial statements and related notes included in the 2022 Annual Report. Results of operations for interim periods are not necessarily indicative of annual results.

Inventories (Tables)

Inventories (Tables)	3 Months Ended
	May 31, 2022
Inventory Disclosure [Abstract]
Schedule of Components of Inventories	Elements of cost include materials, labor, and overhead and consist of the following: May 31, February 28, (in millions) Raw materials and supplies $ 215.0 $ 185.3 In-process inventories 820.9 804.8 Finished case goods 620.5 583.1 $ 1,656.4 $ 1,573.2 the carrying value of certain inventories and recognized the following in cost of product sold within our consolidated results of operations: For the Three Months 2022 2021 (in millions) Loss on inventory write-down $ 6.1 $ 16.0

Derivative Instruments (Tables)

Derivative Instruments (Tables)	3 Months Ended
	May 31, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Aggregate notional value of outstanding derivative instruments	The aggregate notional value of outstanding derivative instruments is as follows: May 31, February 28, (in millions) Derivative instruments designated as hedging instruments Foreign currency contracts $ 2,030.2 $ 1,863.2 Pre-issuance hedge contracts $ — $ 100.0 Derivative instruments not designated as hedging instruments Foreign currency contracts $ 696.0 $ 497.6 Commodity derivative contracts $ 342.0 $ 291.1
Fair value and location of derivative instruments on our balance sheets	The estimated fair value and location of our derivative instruments on our balance sheets are as follows (see Note 4): Assets Liabilities May 31, February 28, May 31, February 28, (in millions) Derivative instruments designated as hedging instruments Foreign currency contracts: Prepaid expenses and other $ 61.9 $ 28.6 Other accrued expenses and liabilities $ 10.1 $ 5.9 Other assets $ 72.2 $ 25.1 Deferred income taxes and other liabilities $ 7.6 $ 8.6 Pre-issuance hedge contracts: Other assets $ — $ — Deferred income taxes and other liabilities $ — $ 0.4 Derivative instruments not designated as hedging instruments Foreign currency contracts: Prepaid expenses and other $ 13.7 $ 2.7 Other accrued expenses and liabilities $ 4.8 $ 3.3 Commodity derivative contracts: Prepaid expenses and other $ 92.3 $ 61.3 Other accrued expenses and liabilities $ 5.4 $ 0.7 Other assets $ 28.5 $ 29.7 Deferred income taxes and other liabilities $ 2.6 $ 0.2
Effect of derivative instruments on our results of operations and OCI	The principal effect of our derivative instruments designated in cash flow hedging relationships on our results of operations, as well as OCI, net of income tax effect, is as follows: Derivative Instruments in Net Location of Net Gain (Loss) Net (in millions) For the Three Months Ended May 31, 2022 Foreign currency contracts $ 79.5 Sales $ (0.6) Cost of product sold 11.1 Pre-issuance hedge contracts 15.7 Interest expense (0.5) $ 95.2 $ 10.0 For the Three Months Ended May 31, 2021 Foreign currency contracts $ 19.3 Sales $ (0.2) Cost of product sold 9.0 Pre-issuance hedge contracts — Interest expense (0.6) $ 19.3 $ 8.2 The effect of our undesignated derivative instruments on our results of operations is as follows: Derivative Instruments Not Location of Net Gain (Loss) Net (in millions) For the Three Months Ended May 31, 2022 Commodity derivative contracts Cost of product sold $ 48.5 Foreign currency contracts Selling, general, and administrative expenses 6.2 $ 54.7 For the Three Months Ended May 31, 2021 Commodity derivative contracts Cost of product sold $ 24.1 Foreign currency contracts Selling, general, and administrative expenses (2.2) $ 21.9

Fair Value of Financial Instr_2

Fair Value of Financial Instruments (Tables)	3 Months Ended
	May 31, 2022
Fair Value Disclosures [Abstract]
Fair value measurement inputs	The inputs used to estimate the fair value of the November 2018 Canopy Warrants are as follows (1) (2) : May 31, 2022 February 28, 2022 Tranche A Warrants (3) Tranche B Warrants (4) Tranche A Warrants (3) Tranche B Warrants (4) Exercise price (5) C$ 50.40 C$ 76.68 C$ 50.40 C$ 76.68 Valuation date stock price (6) C$ 6.33 C$ 6.33 C$ 9.04 C$ 9.04 Remaining contractual term (7) 1.4 years 4.4 years 1.7 years 4.7 years Expected volatility (8) 85.0 % 85.0 % 75.0 % 75.0 % Risk-free interest rate (9) 2.6 % 2.7 % 1.4 % 1.7 % Expected dividend yield (10) 0.0 % 0.0 % 0.0 % 0.0 % (1) The exercise price for the Tranche C Warrants is based on the VWAP Exercise Price. The Tranche C Warrants are not included in the table as there is no fair value assigned. (2) In connection with the Acreage Transaction, we obtained other rights which include a share repurchase credit. If Canopy has not purchased the lesser of 27,378,866 Canopy common shares, or C$1,583.0 million worth of Canopy common shares for cancellation between April 18, 2019, and two-years after the full exercise of the Tranche A Warrants, we will be credited an amount that will reduce the aggregate exercise price otherwise payable upon each exercise of the Tranche B Warrants and Tranche C Warrants. The credit will be an amount equal to the difference between C$1,583.0 million and the actual price paid by Canopy in purchasing its common shares for cancellation. The likelihood of receiving the share repurchase credit if we were to fully exercise the Tranche A Warrants is remote, therefore, no fair value has been assigned. (3) The fair value is estimated using the Black-Scholes option-pricing model (Level 2 fair value measurement). (4) The fair value is estimated using Monte Carlo simulations (Level 2 fair value measurement). (5) Based on the exercise price from the applicable underlying agreements. (6) Based on the closing market price for Canopy common stock on the TSX as of the applicable date. (7) Based on the expiration date of the warrants. (8) Based on consideration of historical and/or implied volatility levels of the underlying equity security and limited consideration of historical peer group volatility levels. (9) Based on the implied yield currently available on Canadian Treasury zero coupon issues with a remaining term equal to the expiration date of the applicable warrants. (10) Based on historical dividend levels. The inputs used to estimate the fair value of the Canopy Debt Securities are as follows: May 31, February 28, Conversion price (1) C$ 48.17 C$ 48.17 Valuation date stock price (2) C$ 6.33 C$ 9.04 Remaining term (3) 1.1 years 1.4 years Expected volatility (4) 85.0 % 75.0 % Risk-free interest rate (5) 2.5 % 1.4 % Expected dividend yield (6) 0.0 % 0.0 % (1) Based on the rate which the Canopy Debt Securities may be converted into equity shares, or the equivalent amount of cash, at the option of the issuer. (2) Based on the closing market price for Canopy common stock on the TSX as of the applicable date. (3) Based on the contractual maturity date of the notes. (4) Based on consideration of historical and/or implied volatility levels of the underlying equity security, adjusted for certain risks associated with debt securities, as appropriate. (5) Based on the implied yield currently available on Canadian Treasury zero coupon issues with a term equal to the remaining contractual term of the Canopy Debt Securities. (6) Based on historical dividend levels.
Financial assets and liabilities measured at estimated fair value on a recurring basis	The following table presents our financial assets and liabilities measured at estimated fair value on a recurring basis: Fair Value Measurements Using Quoted Significant Significant Total (in millions) May 31, 2022 Assets: Foreign currency contracts $ — $ 147.8 $ — $ 147.8 Commodity derivative contracts $ — $ 120.8 $ — $ 120.8 November 2018 Canopy Warrants (1) $ — $ 17.6 $ — $ 17.6 Canopy Debt Securities (1) $ — $ 146.1 $ — $ 146.1 Liabilities: Foreign currency contracts $ — $ 22.5 $ — $ 22.5 Commodity derivative contracts $ — $ 8.0 $ — $ 8.0 February 28, 2022 Assets: Foreign currency contracts $ — $ 56.4 $ — $ 56.4 Commodity derivative contracts $ — $ 91.0 $ — $ 91.0 November 2018 Canopy Warrants (1) $ — $ 36.3 $ — $ 36.3 Canopy Debt Securities (1) $ — $ 146.6 $ — $ 146.6 Liabilities: Foreign currency contracts $ — $ 17.8 $ — $ 17.8 Commodity derivative contracts $ — $ 0.9 $ — $ 0.9 Pre-issuance hedge contracts $ — $ 0.4 $ — $ 0.4 (1) Unrealized net gain (loss) from the changes in fair value of our securities measured at fair value recognized in income (loss) from unconsolidated investments, are as follows: For the Three Months 2022 2021 (in millions) November 2018 Canopy Warrants $ (18.7) $ (736.2) Canopy Debt Securities (3.7) (8.9) $ (22.4) $ (745.1)
Assets and liabilities measured at estimated fair value on a nonrecurring basis	The following table presents our assets and liabilities measured at estimated fair value on a nonrecurring basis for which an impairment assessment was performed for the period presented: Fair Value Measurements Using Quoted Significant Significant Total Losses (in millions) For the Three Months Ended May 31, 2021 Long-lived assets $ — $ — $ 20.0 $ 665.9

Goodwill (Tables)

Goodwill (Tables)	3 Months Ended
	May 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Changes in the carrying amount of goodwill	The changes in the carrying amount of goodwill are as follows: Beer Wine and Spirits Consolidated (in millions) Balance, February 28, 2021 $ 5,125.6 $ 2,667.9 $ 7,793.5 Purchase accounting allocations (1) — 79.6 79.6 Foreign currency translation adjustments (4.9) (5.8) (10.7) Balance, February 28, 2022 5,120.7 2,741.7 7,862.4 Purchase accounting allocations (2) — 25.9 25.9 Foreign currency translation adjustments 30.1 (3.3) 26.8 Balance, May 31, 2022 $ 5,150.8 $ 2,764.3 $ 7,915.1 (1) Preliminary purchase accounting allocations associated with the acquisition of My Favorite Neighbor and purchase accounting allocations associated with the acquisition of Empathy Wines. (2) Preliminary purchase accounting allocations associated with the acquisitions of My Favorite Neighbor, Lingua Franca, and Austin Cocktails. Acquisitions Austin Cocktails In April 2022, we acquired the remaining 73% ownership interest in Austin Cocktails, which included a portfolio of small batch, RTD cocktails. This transaction primarily included the acquisition of goodwill and a trademark. In addition, the purchase price for Austin Cocktails includes an earn-out over five years based on performance. The results of operations of Austin Cocktails are reported in the Wine and Spirits segment and have been included in our consolidated results of operations from the date of acquisition. For additional information on this transaction refer to Note 13. Lingua Franca In March 2022, we acquired the Lingua Franca business, including a collection of Oregon-based luxury wines, a vineyard, and a production facility. This transaction also includes the acquisition of a trademark and inventory. In addition, the purchase price for Lingua Franca includes an earn-out over seven years based on performance. The results of operations of Lingua Franca are reported in the Wine and Spirits segment and have been included in our consolidated results of operations from the date of acquisition. My Favorite Neighbor In November 2021, we acquired the remaining 65% ownership interest in My Favorite Neighbor, a super-luxury, DTC focused wine business as well as certain wholesale distributed brands. This transaction primarily included the acquisition of goodwill, trademarks, inventory, and property, plant, and equipment. In addition, the My Favorite Neighbor transaction includes an earn-out over 10 years based on performance, with a 50% minimum guarantee due at the end of the earn-out period. The results of operations of My Favorite Neighbor are reported in the Wine and Spirits segment and have been included in our consolidated results of operations from the date of acquisition.

Intangible Assets (Tables)

Intangible Assets (Tables)	3 Months Ended
	May 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Major components of intangible assets, Amortizable intangible assets	The major components of intangible assets are as follows: May 31, 2022 February 28, 2022 Gross Net Gross Net (in millions) Amortizable intangible assets Customer relationships $ 87.1 $ 20.7 $ 87.1 $ 21.7 Other 20.8 — 20.9 — Total $ 107.9 20.7 $ 108.0 21.7 Nonamortizable intangible assets Trademarks 2,745.0 2,733.5 Total intangible assets $ 2,765.7 $ 2,755.2
Major components of intangible assets, Nonamortizable intangible assets	The major components of intangible assets are as follows: May 31, 2022 February 28, 2022 Gross Net Gross Net (in millions) Amortizable intangible assets Customer relationships $ 87.1 $ 20.7 $ 87.1 $ 21.7 Other 20.8 — 20.9 — Total $ 107.9 20.7 $ 108.0 21.7 Nonamortizable intangible assets Trademarks 2,745.0 2,733.5 Total intangible assets $ 2,765.7 $ 2,755.2

Equity Method Investments (Tabl

Equity Method Investments (Tables)	3 Months Ended
	May 31, 2022
Equity Method Investments and Joint Ventures [Abstract]
Equity method investments	Our equity method investments are as follows: May 31, 2022 February 28, 2022 Carrying Value Ownership Percentage Carrying Value Ownership Percentage (in millions) Canopy Equity Method Investment (1) (2) $ 2,353.5 36.1 % $ 2,503.5 36.1 % Other equity method investments 180.5 20%-50% 185.2 20%-50% $ 2,534.0 $ 2,688.7 (1) The fair value based on the closing price of the underlying equity security as of May 31, 2022, and February 28, 2022, was $711.9 million and $1,014.8 million, respectively. Refer to discussion below on other-than-temporary impairment considerations. (2) Includes the following: Common Shares Purchase Price (in millions) November 2017 Canopy Investment 18.9 $ 130.1 November 2018 Canopy Investment 104.5 2,740.3 May 2020 Canopy Investment 18.9 173.9 142.3 $ 3,044.3 For the Three Months 2022 2021 (in millions) Equity in earnings (losses) from Canopy and related activities $ (165.0) $ (155.8) The following table presents summarized financial information for Canopy prepared in accordance with U.S. GAAP. We recognize our equity in earnings (losses) for Canopy on a two-month lag. Accordingly, we recognized our share of Canopy’s earnings (losses) for the periods January through March 2022 and January through March 2021 in our three months ended May 31, 2022, and May 31, 2021, results, respectively. The three months ended May 31, 2022, includes substantial costs designed to drive efficiency and accelerate Canopy’s path to profitability. The amounts shown represent 100% of Canopy’s reported results of operations for the respective periods. For the Three Months 2022 2021 (in millions) Net sales $ 88.2 $ 117.3 Gross profit (loss) $ (125.7) $ 7.7 Net income (loss) $ (456.8) $ (487.1) Net income (loss) attributable to Canopy $ (453.7) $ (552.9)

Borrowings (Tables)

Borrowings (Tables)	3 Months Ended
	May 31, 2022
Debt Disclosure [Abstract]
Borrowings	Borrowings consist of the following: May 31, 2022 February 28, Current Long-term Total Total (in millions) Short-term borrowings Commercial paper $ 124.0 $ 323.0 $ 124.0 $ 323.0 Long-term debt Term loan credit facilities $ — $ 300.0 $ 300.0 $ 300.0 Senior notes 567.4 9,965.7 10,533.1 9,773.6 Other 7.7 12.5 20.2 19.9 $ 575.1 $ 10,278.2 $ 10,853.3 $ 10,093.5 As of May 31, 2022, aggregate credit facilities under the 2022 Credit Agreement and the 2022 Term Credit Agreement consist of the following: Amount Maturity (in millions) 2022 Credit Agreement Revolving credit facility (1) (2) $ 2,250.0 Apr 14, 2027 2022 Term Credit Agreement Five-Year Term Facility (1) (3) $ 491.3 Jun 28, 2024 (1) Contractual interest rate varies based on our debt rating (as defined in the respective agreement) and is a function of SOFR plus a margin and a credit spread adjustment, or the base rate plus a margin, or, in certain circumstances where SOFR cannot be adequately ascertained or available, an alternative benchmark rate plus a margin. (2) We and/or CB International are the borrower under the $2,250.0 million revolving credit facility. Includes a sub-facility for letters of credit of up to $200.0 million. (3) We are the borrower under the Five-Year Term Facility. As of May 31, 2022, information with respect to borrowings under the 2022 Credit Agreement and the 2022 Term Credit Agreement is as follows: Outstanding Interest SOFR Outstanding Remaining borrowing capacity (1) (in millions) 2022 Credit Agreement Revolving credit facility $ — — % — % $ 12.0 $ 2,114.0 2022 Term Credit Agreement Five-Year Term Facility $ 300.0 1.7 % 0.88 % (1) Net of outstanding revolving credit facility borrowings and outstanding letters of credit under the 2022 Credit Agreement and outstanding borrowings under our commercial paper program of $124.0 million (excluding unamortized discount) (see “Commercial paper program” below). Date of Redemption Principal Maturity Interest Payments Stated Redemption Date Stated Basis Points (in millions, except basis points) 3.60% Senior Notes (1) $ 550.0 May 2024 May/Nov (2) 15 4.35% Senior Notes (1) (3) $ 600.0 May 2027 May/Nov Apr 2027 25 4.75% Senior Notes (1) (3) $ 700.0 May 2032 May/Nov Feb 2032 30 (1) Senior unsecured obligations which rank equally in right of payment to all of our existing and future senior unsecured indebtedness. (2) Redeemable, in whole or in part, at our option at any time at a redemption price equal to 100% of the outstanding principal amount, plus accrued and unpaid interest and a make-whole payment based on the present value of the future payments at the applicable treasury rate plus the stated basis points. (3) Redeemable, in whole or in part, at our option at any time prior to the stated redemption date as defined in the indenture, at a redemption price equal to 100% of the outstanding principal amount, plus accrued and unpaid interest and a make-whole payment based on the present value of the future payments at the applicable treasury rate plus the stated basis points as defined in the indenture. On or after the stated redemption date, redeemable, in whole or in part, at our option at any time at a redemption price equal to 100% of the outstanding principal amount, plus accrued and unpaid interest.
Schedule of maturities of long-term debt	As of May 31, 2022, the required principal repayments under long-term debt obligations (excluding unamortized debt issuance costs and unamortized discounts of $63.6 million and $21.3 million, respectively) for the remaining nine months of Fiscal 2023 and for each of the five succeeding fiscal years and thereafter are as follows: (in millions) Fiscal 2023 (1) $ 574.1 Fiscal 2024 7.0 Fiscal 2025 1,254.0 Fiscal 2026 902.1 Fiscal 2027 600.9 Fiscal 2028 1,800.0 Thereafter 5,800.1 $ 10,938.2 (1) Includes $568.0 million remaining principal amount of the 3.20% February 2018 Senior Notes and 4.25% May 2013 Senior Notes, fully redeemed in June 2022.

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	3 Months Ended
	May 31, 2022
Equity [Abstract]
Number of shares of common stock issued and treasury stock, and associated share activity	The number of shares of common stock issued and treasury stock, and associated share activity, are as follows: Common Stock Treasury Stock Class A Class B Class 1 Class A Class B Balance at February 28, 2022 187,263,859 28,212,340 2,248,679 22,824,607 5,005,800 Share repurchases — — — 4,065,508 — Conversion of shares 655 (655) — — — Exercise of stock options — — 35 (108,228) — Vesting of restricted stock units (1) — — — (71,064) — Vesting of performance share units (1) — — — (16,326) — Balance at May 31, 2022 187,264,514 28,211,685 2,248,714 26,694,497 5,005,800 Balance at February 28, 2021 187,204,280 28,270,288 612,936 17,070,550 5,005,800 Share repurchases — — — 1,696,722 — Conversion of shares 43,441 (42,810) (631) — — Exercise of stock options — — 781 (116,058) — Vesting of restricted stock units (1) — — — (66,157) — Vesting of performance share units (1) — — — (7,934) — Balance at May 31, 2021 187,247,721 28,227,478 613,086 18,577,123 5,005,800 (1) Net of the following shares withheld to satisfy tax withholding requirements: For the Three 2022 Restricted Stock Units 37,308 Performance Share Units 4,919 2021 Restricted Stock Units 36,048 Performance Share Units 4,565
Summary of share repurchase activity	As of June 30, 2022, total shares repurchased under the 2018 Authorization and the 2021 Authorization are as follows: Class A Common Shares Repurchase Dollar Value Number of (in millions, except share data) 2018 Authorization $ 3,000.0 $ 3,000.0 13,331,156 2021 Authorization $ 2,000.0 $ 737.1 3,051,467

Net Income (Loss) Per Common _2

Net Income (Loss) Per Common Share Attributable to CBI (Tables)	3 Months Ended
	May 31, 2022
Earnings Per Share [Abstract]
Basic and diluted net income (loss) per common share attributable to CBI	The computation of basic and diluted net income (loss) per common share is as follows: For the Three Months Ended May 31, 2022 May 31, 2021 Class A Stock Class B Stock Class A Stock Class B Stock (in millions, except per share data) Net income (loss) attributable to CBI allocated – basic $ 345.6 $ 43.9 $ (807.8) $ (100.3) Conversion of Class B common shares into Class A common shares 43.9 — — — Effect of stock-based awards on allocated net income (loss) — (0.1) — — Net income (loss) attributable to CBI allocated – diluted $ 389.5 $ 43.8 $ (807.8) $ (100.3) Weighted average common shares outstanding – basic 165.335 23.206 170.602 23.247 Conversion of Class B common shares into Class A common shares (1) 23.206 — — — Stock-based awards, primarily stock options (1) 0.792 — — — Weighted average common shares outstanding – diluted 189.333 23.206 170.602 23.247 Net income (loss) per common share attributable to CBI – $ 2.09 $ 1.89 $ (4.74) $ (4.31) Net income (loss) per common share attributable to CBI – $ 2.06 $ 1.89 $ (4.74) $ (4.31) (1) For the three months ended May 31, 2021, we have excluded the following weighted average common shares outstanding from the calculation of diluted net income (loss) per common share, as the effect of including these would have been anti-dilutive, in millions: Class B Stock 23.247 Stock-based awards, primarily stock options 2.034

Comprehensive Income (Loss) A_2

Comprehensive Income (Loss) Attributable to CBI (Tables)	3 Months Ended
	May 31, 2022
Equity [Abstract]
Reconciliation of net income (loss) attributable to CBI to comprehensive income (loss) attributable to CBI	The reconciliation of net income (loss) attributable to CBI to comprehensive income (loss) attributable to CBI is as follows: Before Tax Tax (Expense) Net of Tax (in millions) For the Three Months Ended May 31, 2022 Net income (loss) attributable to CBI $ 389.5 Other comprehensive income (loss) attributable to CBI: Foreign currency translation adjustments: Net gain (loss) $ 170.3 $ — 170.3 Reclassification adjustments — — — Net gain (loss) recognized in other comprehensive income (loss) 170.3 — 170.3 Unrealized gain (loss) on cash flow hedges: Net derivative gain (loss) 105.5 (14.8) 90.7 Reclassification adjustments (10.0) 0.9 (9.1) Net gain (loss) recognized in other comprehensive income (loss) 95.5 (13.9) 81.6 Pension/postretirement adjustments: Net actuarial gain (loss) (0.3) — (0.3) Reclassification adjustments — — — Net gain (loss) recognized in other comprehensive income (loss) (0.3) — (0.3) Before Tax Tax (Expense) Net of Tax (in millions) Share of OCI of equity method investments Net gain (loss) (9.0) 3.8 (5.2) Reclassification adjustments — — — Net gain (loss) recognized in other comprehensive income (loss) (9.0) 3.8 (5.2) Other comprehensive income (loss) attributable to CBI $ 256.5 $ (10.1) 246.4 Comprehensive income (loss) attributable to CBI $ 635.9 For the Three Months Ended May 31, 2021 Net income (loss) attributable to CBI $ (908.1) Other comprehensive income (loss) attributable to CBI: Foreign currency translation adjustments: Net gain (loss) $ 103.0 $ — 103.0 Reclassification adjustments — — — Net gain (loss) recognized in other comprehensive income (loss) 103.0 — 103.0 Unrealized gain (loss) on cash flow hedges: Net derivative gain (loss) 27.5 (9.8) 17.7 Reclassification adjustments (7.8) 0.2 (7.6) Net gain (loss) recognized in other comprehensive income (loss) 19.7 (9.6) 10.1 Pension/postretirement adjustments: Net actuarial gain (loss) (0.2) — (0.2) Reclassification adjustments — — — Net gain (loss) recognized in other comprehensive income (loss) (0.2) — (0.2) Share of OCI of equity method investments Net gain (loss) (18.1) 4.1 (14.0) Reclassification adjustments — — — Net gain (loss) recognized in other comprehensive income (loss) (18.1) 4.1 (14.0) Other comprehensive income (loss) attributable to CBI $ 104.4 $ (5.5) 98.9 Comprehensive income (loss) attributable to CBI $ (809.2)
Accumulated other comprehensive income (loss), net of income tax effect	AOCI, net of income tax effect, includes the following components: Foreign Unrealized Net Pension/ Share of OCI AOCI (in millions) Balance, February 28, 2022 $ (431.4) $ 17.5 $ (4.0) $ 5.2 $ (412.7) OCI: OCI before reclassification adjustments 170.3 90.7 (0.3) (5.2) 255.5 Amounts reclassified from AOCI — (9.1) — — (9.1) OCI 170.3 81.6 (0.3) (5.2) 246.4 Balance, May 31, 2022 $ (261.1) $ 99.1 $ (4.3) $ — $ (166.3)

Business Segment Information (T

Business Segment Information (Tables)	3 Months Ended
	May 31, 2022
Segment Reporting [Abstract]
Comparable adjustments	Comparable Adjustments that impacted comparability in our segment operating income (loss) for each period are as follows: For the Three Months 2022 2021 (in millions) Cost of product sold Net gain (loss) on undesignated commodity derivative contracts $ 48.5 $ 24.1 Recovery of inventory write-down 0.2 — Settlements of undesignated commodity derivative contracts (23.3) (3.4) Flow through of inventory step-up (1.0) — Strategic business development costs — (2.6) Total cost of product sold 24.4 18.1 Selling, general, and administrative expenses Transition services agreements activity (3.4) (2.3) Restructuring and other strategic business development costs (1.4) (0.9) Transaction, integration, and other acquisition-related costs (0.2) — Other gains (losses) (1) 4.5 3.3 Total selling, general, and administrative expenses (0.5) 0.1 Impairment of brewery construction in progress — (665.9) Comparable Adjustments, Operating income (loss) $ 23.9 $ (647.7) (1) The three months ended May 31, 2022, primarily includes a gain of $5.2 million related to the remeasurement of our previously held 27% equity interest in Austin Cocktails to the acquisition date fair value.
Segment information	Segment information is as follows: For the Three Months 2022 2021 (in millions) Beer Net sales $ 1,898.2 $ 1,572.0 Segment operating income (loss) $ 762.8 $ 673.1 Capital expenditures $ 161.8 $ 85.8 Depreciation and amortization $ 68.2 $ 54.0 Wine and Spirits Net sales: Wine $ 404.1 $ 397.7 Spirits 60.9 56.8 Net sales $ 465.0 $ 454.5 Segment operating income (loss) $ 91.0 $ 104.2 Income (loss) from unconsolidated investments $ 1.5 $ 1.3 Equity method investments $ 98.0 $ 128.0 Capital expenditures $ 29.8 $ 25.7 Depreciation and amortization $ 22.3 $ 19.9 Corporate Operations and Other Segment operating income (loss) $ (61.3) $ (54.5) Income (loss) from unconsolidated investments $ (2.0) $ (0.6) Equity method investments $ 82.5 $ 91.9 Capital expenditures $ 5.0 $ 2.4 Depreciation and amortization $ 3.2 $ 3.3 Canopy Net sales $ 88.2 $ 117.3 Segment operating income (loss) $ (418.2) $ (184.2) Capital expenditures $ 0.1 $ 21.0 Depreciation and amortization $ 24.1 $ 22.9 Consolidation and Eliminations Net sales $ (88.2) $ (117.3) Operating income (loss) $ 418.2 $ 184.2 Income (loss) from unconsolidated investments $ (52.0) $ (44.3) Equity method investments $ 2,353.5 $ 2,436.8 Capital expenditures $ (0.1) $ (21.0) Depreciation and amortization $ (24.1) $ (22.9) For the Three Months 2022 2021 (in millions) Comparable Adjustments Operating income (loss) $ 23.9 $ (647.7) Income (loss) from unconsolidated investments $ (135.4) $ (855.6) Consolidated Net sales $ 2,363.2 $ 2,026.5 Operating income (loss) $ 816.4 $ 75.1 Income (loss) from unconsolidated investments (1) $ (187.9) $ (899.2) Equity method investments $ 2,534.0 $ 2,656.7 Capital expenditures $ 196.6 $ 113.9 Depreciation and amortization $ 93.7 $ 77.2 (1) Income (loss) from unconsolidated investments consists of: For the Three Months 2022 2021 (in millions) Unrealized net gain (loss) on securities measured at fair value $ (22.4) $ (745.1) Equity in earnings (losses) from Canopy and related activities (165.0) (155.8) Equity in earnings (losses) from other equity method investees (0.5) 1.7 $ (187.9) $ (899.2)

Inventories - Schedule of Costs

Inventories - Schedule of Costs of Inventory (Details) - USD ($) $ in Millions	May 31, 2022	Feb. 28, 2022
Inventory Disclosure [Abstract]
Raw materials and supplies	$ 215	$ 185.3
In-process inventories	820.9	804.8
Finished case goods	620.5	583.1
Inventories, Total	$ 1,656.4	$ 1,573.2

Inventories - Schedule of Cos_2

Inventories - Schedule of Costs of Products Sold (Details) - USD ($) $ in Millions	3 Months Ended
	May 31, 2022	May 31, 2021
Inventory Disclosure [Abstract]
Loss on inventory write-down	$ 6.1	$ 16

Derivative Instruments - Aggreg

Derivative Instruments - Aggregate Notional Value of Outstanding Derivative Instruments (Details) - USD ($) $ in Millions	May 31, 2022	Feb. 28, 2022
Derivative instruments designated as hedging instruments | Foreign currency contracts
Derivative [Line Items]
Aggregate notional value of derivative instruments	$ 2,030.2	$ 1,863.2
Derivative instruments designated as hedging instruments | Pre-issuance hedge contracts
Derivative [Line Items]
Aggregate notional value of derivative instruments	0	100
Derivative instruments not designated as hedging instruments | Foreign currency contracts
Derivative [Line Items]
Aggregate notional value of derivative instruments	696	497.6
Derivative instruments not designated as hedging instruments | Commodity derivative contracts
Derivative [Line Items]
Aggregate notional value of derivative instruments	$ 342	$ 291.1

Derivative Instruments - Estima

Derivative Instruments - Estimated Fair Value and Location of Derivative Instruments (Details) - USD ($) $ in Millions	May 31, 2022	Feb. 28, 2022
Derivative instruments designated as hedging instruments | Foreign currency contracts | Prepaid expenses and other
Fair value and location of our derivative instruments on our balance sheets
Foreign currency contracts, Assets	$ 61.9	$ 28.6
Derivative instruments designated as hedging instruments | Foreign currency contracts | Other accrued expenses and liabilities
Fair value and location of our derivative instruments on our balance sheets
Foreign currency contracts, Liabilities	10.1	5.9
Derivative instruments designated as hedging instruments | Foreign currency contracts | Other assets
Fair value and location of our derivative instruments on our balance sheets
Foreign currency contracts, Assets	72.2	25.1
Derivative instruments designated as hedging instruments | Foreign currency contracts | Deferred income taxes and other liabilities
Fair value and location of our derivative instruments on our balance sheets
Foreign currency contracts, Liabilities	7.6	8.6
Derivative instruments designated as hedging instruments | Pre-issuance hedge contracts | Other assets
Fair value and location of our derivative instruments on our balance sheets
Foreign currency contracts, Assets	0	0
Derivative instruments designated as hedging instruments | Pre-issuance hedge contracts | Deferred income taxes and other liabilities
Fair value and location of our derivative instruments on our balance sheets
Foreign currency contracts, Liabilities	0	0.4
Derivative instruments not designated as hedging instruments | Foreign currency contracts | Prepaid expenses and other
Fair value and location of our derivative instruments on our balance sheets
Foreign currency contracts, Assets	13.7	2.7
Derivative instruments not designated as hedging instruments | Foreign currency contracts | Other accrued expenses and liabilities
Fair value and location of our derivative instruments on our balance sheets
Foreign currency contracts, Liabilities	4.8	3.3
Derivative instruments not designated as hedging instruments | Commodity derivative contracts | Prepaid expenses and other
Fair value and location of our derivative instruments on our balance sheets
Commodity derivative contracts, Assets	92.3	61.3
Derivative instruments not designated as hedging instruments | Commodity derivative contracts | Other accrued expenses and liabilities
Fair value and location of our derivative instruments on our balance sheets
Commodity derivative contracts, Liabilities	5.4	0.7
Derivative instruments not designated as hedging instruments | Commodity derivative contracts | Other assets
Fair value and location of our derivative instruments on our balance sheets
Commodity derivative contracts, Assets	28.5	29.7
Derivative instruments not designated as hedging instruments | Commodity derivative contracts | Deferred income taxes and other liabilities
Fair value and location of our derivative instruments on our balance sheets
Commodity derivative contracts, Liabilities	$ 2.6	$ 0.2

Derivative Instruments - Effect

Derivative Instruments - Effects of Designated and Undesignated Hedging Instruments (Details) - USD ($) $ in Millions	3 Months Ended
	May 31, 2022	May 31, 2021
Effect of our undesignated derivative instruments on our results of operations
Net Gain (Loss) Recognized in Income (Loss)	$ 54.7	$ 21.9
Foreign currency contracts | Selling, general, and administrative expenses
Effect of our undesignated derivative instruments on our results of operations
Net Gain (Loss) Recognized in Income (Loss)	6.2	(2.2)
Commodity derivative contracts | Cost of product sold
Effect of our undesignated derivative instruments on our results of operations
Net Gain (Loss) Recognized in Income (Loss)	48.5	24.1
Cash flow hedging
Effect of our derivative instruments designated in cash flow hedging relationships on our results of operations, net of income tax effect
Net Gain (Loss) Recognized in OCI	95.2	19.3
Net Gain (Loss) Reclassified from AOCI to Income (Loss)	10	8.2
Cash flow hedging | Foreign currency contracts
Effect of our derivative instruments designated in cash flow hedging relationships on our results of operations, net of income tax effect
Net Gain (Loss) Recognized in OCI	79.5	19.3
Cash flow hedging | Foreign currency contracts | Sales
Effect of our derivative instruments designated in cash flow hedging relationships on our results of operations, net of income tax effect
Net Gain (Loss) Reclassified from AOCI to Income (Loss)	(0.6)	(0.2)
Cash flow hedging | Foreign currency contracts | Cost of product sold
Effect of our derivative instruments designated in cash flow hedging relationships on our results of operations, net of income tax effect
Net Gain (Loss) Reclassified from AOCI to Income (Loss)	11.1	9
Cash flow hedging | Pre-issuance hedge contracts
Effect of our derivative instruments designated in cash flow hedging relationships on our results of operations, net of income tax effect
Net Gain (Loss) Recognized in OCI	15.7	0
Cash flow hedging | Pre-issuance hedge contracts | Interest expense
Effect of our derivative instruments designated in cash flow hedging relationships on our results of operations, net of income tax effect
Net Gain (Loss) Reclassified from AOCI to Income (Loss)	$ (0.5)	$ (0.6)

Derivative Instruments - Narrat

Derivative Instruments - Narrative (Details) $ in Millions	3 Months Ended
	May 31, 2022 USD ($)
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Fair value of derivative instruments in a net liability position due to counterparties	$ 3.9
Amount of net gains (losses), net of income tax effect, to be reclassified from AOCI to our results of operations within the next 12 months	$ 45.6

Fair Value of Financial Instr_3

Fair Value of Financial Instruments - Fair Value Measurement Inputs (Details) $ / shares in Units, $ in Millions	May 31, 2022 CAD ($) $ / shares shares	Feb. 28, 2022 $ / shares
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Common shares to be repurchased for cancellation under share repurchase credit feature (in shares) | shares	27,378,866
Tranche B Warrants and Tranche C Warrants | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Dollar value of common shares to be repurchased for cancellation under share repurchase credit feature, C$ | $	$ 1,583
Significant Other Observable Inputs (Level 2) | Warrants | Tranche A Warrants | Exercise price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants outstanding, measurement input, C$ per share	$ 50.40	$ 50.40
Significant Other Observable Inputs (Level 2) | Warrants | Tranche A Warrants | Valuation date stock price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants outstanding, measurement input, C$ per share	$ 6.33	$ 9.04
Significant Other Observable Inputs (Level 2) | Warrants | Tranche A Warrants | Remaining term
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants outstanding, term	1 year 4 months 24 days	1 year 8 months 12 days
Significant Other Observable Inputs (Level 2) | Warrants | Tranche A Warrants | Expected volatility
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants outstanding, measurement input, decimal	0.850	0.750
Significant Other Observable Inputs (Level 2) | Warrants | Tranche A Warrants | Risk-free interest rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants outstanding, measurement input, decimal	0.026	0.014
Significant Other Observable Inputs (Level 2) | Warrants | Tranche A Warrants | Expected dividend yield
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants outstanding, measurement input, decimal	0	0
Significant Other Observable Inputs (Level 2) | Warrants | Tranche B Warrants | Exercise price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants outstanding, measurement input, C$ per share	$ 76.68	$ 76.68
Significant Other Observable Inputs (Level 2) | Warrants | Tranche B Warrants | Valuation date stock price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants outstanding, measurement input, C$ per share	$ 6.33	$ 9.04
Significant Other Observable Inputs (Level 2) | Warrants | Tranche B Warrants | Remaining term
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants outstanding, term	4 years 4 months 24 days	4 years 8 months 12 days
Significant Other Observable Inputs (Level 2) | Warrants | Tranche B Warrants | Expected volatility
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants outstanding, measurement input, decimal	0.850	0.750
Significant Other Observable Inputs (Level 2) | Warrants | Tranche B Warrants | Risk-free interest rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants outstanding, measurement input, decimal	0.027	0.017
Significant Other Observable Inputs (Level 2) | Warrants | Tranche B Warrants | Expected dividend yield
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants outstanding, measurement input, decimal	0	0
Significant Other Observable Inputs (Level 2) | Convertible debt securities | Conversion price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Debt instrument, measurement input, C$ per share	$ 48.17	$ 48.17
Significant Other Observable Inputs (Level 2) | Convertible debt securities | Valuation date stock price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Debt instrument, measurement input, C$ per share	$ 6.33	$ 9.04
Significant Other Observable Inputs (Level 2) | Convertible debt securities | Remaining term
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Debt instrument, term	1 year 1 month 6 days	1 year 4 months 24 days
Significant Other Observable Inputs (Level 2) | Convertible debt securities | Expected volatility
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Debt Instrument, measurement input, decimal	0.850	0.750
Significant Other Observable Inputs (Level 2) | Convertible debt securities | Risk-free interest rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Debt Instrument, measurement input, decimal	0.025	0.014
Significant Other Observable Inputs (Level 2) | Convertible debt securities | Expected dividend yield
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Debt Instrument, measurement input, decimal	0	0

Fair Value of Financial Instr_4

Fair Value of Financial Instruments - Debt and Investments (Details) shares in Millions, $ in Millions, $ in Millions			3 Months Ended
	Jun. 30, 2018 USD ($)	Jun. 30, 2018 CAD ($)	May 31, 2022 USD ($) shares	May 31, 2021 USD ($)	Feb. 28, 2022 USD ($)
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Payments to acquire investments			$ 0	$ 8.5
Long-term debt, including current portion			10,853.3		$ 10,093.5
Carrying amount
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term debt, including current portion			10,853.3		10,093.5
Fair value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term debt, including current portion			$ 10,442.9		$ 10,345.3
Warrants | Tranche A Warrants
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Number of common shares to be acquired upon exercise of warrants (in shares) | shares			88.5
Warrants | Tranche B Warrants
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Number of common shares to be acquired upon exercise of warrants (in shares) | shares			38.4
Warrants | Tranche C Warrants
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Number of common shares to be acquired upon exercise of warrants (in shares) | shares			12.8
Convertible debt securities
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Payments to acquire investments	$ 150.5	$ 200

Fair Value of Financial Instr_5

Fair Value of Financial Instruments - Recurring Basis Measurements (Details) - USD ($) shares in Millions, $ in Millions	3 Months Ended
	May 31, 2022	May 31, 2021	Feb. 28, 2022
Fair Value, Net Asset (Liability) [Abstract]
Debt securities	$ 172.3		$ 191.4
Debt and Equity Securities, Unrealized Gain (Loss), Excluding Other-than-temporary Impairment [Abstract]
Unrealized net gain (loss) on securities measured at fair value	$ (22.4)	$ (745.1)
Equity method investment, number of common shares acquired (in shares)	142.3
Convertible debt securities
Debt and Equity Securities, Unrealized Gain (Loss), Excluding Other-than-temporary Impairment [Abstract]
Unrealized net gain (loss) on securities measured at fair value	$ (3.7)	(8.9)
Warrants | November 2018 Canopy Warrants
Debt and Equity Securities, Unrealized Gain (Loss), Excluding Other-than-temporary Impairment [Abstract]
Unrealized net gain (loss) on securities measured at fair value	(18.7)	$ (736.2)
Recurring | Foreign currency contracts
Fair Value, Net Asset (Liability) [Abstract]
Derivative asset	147.8		56.4
Derivative liability	22.5		17.8
Recurring | Commodity derivative contracts
Fair Value, Net Asset (Liability) [Abstract]
Derivative asset	120.8		91
Derivative liability	8		0.9
Recurring | Equity securities
Fair Value, Net Asset (Liability) [Abstract]
Equity securities	17.6		36.3
Recurring | Convertible debt securities
Fair Value, Net Asset (Liability) [Abstract]
Debt securities	146.1		146.6
Recurring | Pre-issuance hedge contracts
Fair Value, Net Asset (Liability) [Abstract]
Derivative liability			0.4
Recurring | Quoted Prices in Active Markets (Level 1) | Foreign currency contracts
Fair Value, Net Asset (Liability) [Abstract]
Derivative asset	0		0
Derivative liability	0		0
Recurring | Quoted Prices in Active Markets (Level 1) | Commodity derivative contracts
Fair Value, Net Asset (Liability) [Abstract]
Derivative asset	0		0
Derivative liability	0		0
Recurring | Quoted Prices in Active Markets (Level 1) | Equity securities
Fair Value, Net Asset (Liability) [Abstract]
Equity securities	0		0
Recurring | Quoted Prices in Active Markets (Level 1) | Convertible debt securities
Fair Value, Net Asset (Liability) [Abstract]
Debt securities	0		0
Recurring | Quoted Prices in Active Markets (Level 1) | Pre-issuance hedge contracts
Fair Value, Net Asset (Liability) [Abstract]
Derivative liability			0
Recurring | Significant Other Observable Inputs (Level 2) | Foreign currency contracts
Fair Value, Net Asset (Liability) [Abstract]
Derivative asset	147.8		56.4
Derivative liability	22.5		17.8
Recurring | Significant Other Observable Inputs (Level 2) | Commodity derivative contracts
Fair Value, Net Asset (Liability) [Abstract]
Derivative asset	120.8		91
Derivative liability	8		0.9
Recurring | Significant Other Observable Inputs (Level 2) | Equity securities
Fair Value, Net Asset (Liability) [Abstract]
Equity securities	17.6		36.3
Recurring | Significant Other Observable Inputs (Level 2) | Convertible debt securities
Fair Value, Net Asset (Liability) [Abstract]
Debt securities	146.1		146.6
Recurring | Significant Other Observable Inputs (Level 2) | Pre-issuance hedge contracts
Fair Value, Net Asset (Liability) [Abstract]
Derivative liability			0.4
Recurring | Significant Unobservable Inputs (Level 3) | Foreign currency contracts
Fair Value, Net Asset (Liability) [Abstract]
Derivative asset	0		0
Derivative liability	0		0
Recurring | Significant Unobservable Inputs (Level 3) | Commodity derivative contracts
Fair Value, Net Asset (Liability) [Abstract]
Derivative asset	0		0
Derivative liability	0		0
Recurring | Significant Unobservable Inputs (Level 3) | Equity securities
Fair Value, Net Asset (Liability) [Abstract]
Equity securities	0		0
Recurring | Significant Unobservable Inputs (Level 3) | Convertible debt securities
Fair Value, Net Asset (Liability) [Abstract]
Debt securities	$ 0		0
Recurring | Significant Unobservable Inputs (Level 3) | Pre-issuance hedge contracts
Fair Value, Net Asset (Liability) [Abstract]
Derivative liability			$ 0

Fair Value of Financial Instr_6

Fair Value of Financial Instruments - Nonrecurring Basis Measurements (Details) - USD ($) $ in Millions	3 Months Ended
	May 31, 2022	May 31, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Long-lived assets, total losses	$ 0	$ 665.9
Nonrecurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Long-lived assets, total losses		665.9
Nonrecurring | Quoted Prices in Active Markets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Long-lived assets		0
Nonrecurring | Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Long-lived assets		0
Nonrecurring | Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Long-lived assets		$ 20

Fair Value of Financial Instr_7

Fair Value of Financial Instruments - Impairment of Long-Lived Assets and Long-Lived Assets Held for Sale (Details) - USD ($) $ in Millions	3 Months Ended
	May 31, 2022	May 31, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impairment of brewery construction in progress	$ 0	$ 665.9
Nonrecurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impairment of brewery construction in progress		665.9
Nonrecurring | Mexicali Brewery | Construction in progress | Operating Segments | Beer
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Long-lived assets, carrying value		685.9
Long-lived assets, estimated fair value		20
Impairment of brewery construction in progress		$ 665.9

Goodwill (Details)

Goodwill (Details) - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	May 31, 2022	Feb. 28, 2022	Apr. 30, 2022	Mar. 31, 2022	Nov. 30, 2021
Changes in the carrying amount of goodwill [Roll Forward]
Goodwill, beginning of period	$ 7,862.4	$ 7,793.5
Purchase accounting allocations	25.9	79.6
Foreign currency translation adjustments	26.8	(10.7)
Goodwill, end of period	7,915.1	7,862.4
Austin Cocktails Acquisition
Changes in the carrying amount of goodwill [Roll Forward]
Earn-out period			5 years
Lingua Franca Business Acquisition
Changes in the carrying amount of goodwill [Roll Forward]
Earn-out period				7 years
My Favorite Neighbor Acquisition
Changes in the carrying amount of goodwill [Roll Forward]
Earn-out period					10 years
My Favorite Neighbor Acquisition | Minimum
Changes in the carrying amount of goodwill [Roll Forward]
Percentage of earn-out guaranteed					50%
Operating Segments | Beer
Changes in the carrying amount of goodwill [Roll Forward]
Goodwill, beginning of period	5,120.7	5,125.6
Purchase accounting allocations	0	0
Foreign currency translation adjustments	30.1	(4.9)
Goodwill, end of period	5,150.8	5,120.7
Operating Segments | Wine and Spirits
Changes in the carrying amount of goodwill [Roll Forward]
Goodwill, beginning of period	2,741.7	2,667.9
Purchase accounting allocations	25.9	79.6
Foreign currency translation adjustments	(3.3)	(5.8)
Goodwill, end of period	$ 2,764.3	$ 2,741.7
Operating Segments | Wine and Spirits | Austin Cocktails Acquisition
Changes in the carrying amount of goodwill [Roll Forward]
Remaining equity interest			73%
Operating Segments | Wine and Spirits | My Favorite Neighbor Acquisition
Changes in the carrying amount of goodwill [Roll Forward]
Remaining equity interest					65%

Intangible Assets - Component o

Intangible Assets - Component of Intangible Assets (Details) - USD ($) $ in Millions	May 31, 2022	Feb. 28, 2022
Finite-Lived Intangible Assets [Line Items]
Amortizable intangible assets, Gross Carrying Amount	$ 107.9	$ 108
Amortizable intangible assets, Net Carrying Amount	20.7	21.7
Indefinite-lived Intangible Assets [Line Items]
Intangible assets	2,765.7	2,755.2
Trademarks
Indefinite-lived Intangible Assets [Line Items]
Nonamortizable intangible assets, Net Carrying Amount	2,745	2,733.5
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Amortizable intangible assets, Gross Carrying Amount	87.1	87.1
Amortizable intangible assets, Net Carrying Amount	20.7	21.7
Other
Finite-Lived Intangible Assets [Line Items]
Amortizable intangible assets, Gross Carrying Amount	20.8	20.9
Amortizable intangible assets, Net Carrying Amount	$ 0	$ 0

Equity Method Investments (Deta

Equity Method Investments (Details) $ / shares in Units, $ / shares in Units, shares in Millions, $ in Millions, $ in Millions				1 Months Ended	3 Months Ended
	Jun. 30, 2022 CAD ($)	Jun. 29, 2022 CAD ($)	May 31, 2022 USD ($) shares	Jul. 30, 2022 USD ($)	May 31, 2022 USD ($) shares	May 31, 2021 USD ($)	Jun. 30, 2022 $ / shares	May 31, 2022 $ / shares	Feb. 28, 2022 USD ($)	Sep. 01, 2020
Schedule of Equity Method Investments [Line Items]
Equity method investments, carrying value			$ 2,534		$ 2,534	$ 2,656.7			$ 2,688.7
Equity method investment, number of common shares acquired (in shares) | shares			142.3		142.3
Payments to acquire investments			$ 3,044.3
Net sales					$ 2,363.2	2,026.5
Gross profit (loss)					1,255	1,119.3
Net income (loss)					399.3	(897.3)
Net income (loss) attributable to CBI					389.5	(908.1)
Subsequent Event | Common Stock | Canopy
Schedule of Equity Method Investments [Line Items]
Trading days threshold for shares issuable	10 days
Convertible Debt Securities [Member] | Subsequent Event
Schedule of Equity Method Investments [Line Items]
Sale of debt securities, C$		$ 100
Value of debt securities held, C$	$ 100
Convertible Debt Securities [Member] | Subsequent Event | Canopy
Schedule of Equity Method Investments [Line Items]
Sale of debt securities, C$		$ 255
Percentage of principal value of debt securities		0.99
Canopy Equity Method Investment
Schedule of Equity Method Investments [Line Items]
Net sales					88.2	117.3
Gross profit (loss)					(125.7)	7.7
Net income (loss)					(456.8)	(487.1)
Net income (loss) attributable to CBI					(453.7)	(552.9)
Minimum | Common Stock | Canopy | Forecast
Schedule of Equity Method Investments [Line Items]
Value of exchanged shares receivable in transaction				$ 30.7
Minimum | Subsequent Event | Common Stock | Canopy
Schedule of Equity Method Investments [Line Items]
Exchange price per share for shares issuable (in dollars per share) | $ / shares							$ 2.50
Maximum | Common Stock | Canopy | Forecast
Schedule of Equity Method Investments [Line Items]
Value of exchanged shares receivable in transaction				$ 21.9
Maximum | Subsequent Event | Common Stock | Canopy
Schedule of Equity Method Investments [Line Items]
Exchange price per share for shares issuable (in dollars per share) | $ / shares							$ 3.50
Canopy Equity Method Investment
Schedule of Equity Method Investments [Line Items]
Equity method investments, carrying value			$ 2,353.5		$ 2,353.5				$ 2,503.5
Equity method investment, ownership percentage			36.10%		36.10%				36.10%
Fair value of equity method investment			$ 711.9		$ 711.9				$ 1,014.8
Equity in earnings (losses) from Canopy and related activities					(165)	(155.8)
Canopy Equity Method Investment | Minimum | Valuation date stock price
Schedule of Equity Method Investments [Line Items]
Equity method investment impairment, measurement input, C$ per share | $ / shares								$ 20.54
Other equity method investments
Schedule of Equity Method Investments [Line Items]
Equity method investments, carrying value			$ 180.5		180.5				$ 185.2
Equity in earnings (losses) from Canopy and related activities					$ (0.5)	$ 1.7
Other equity method investments | Minimum
Schedule of Equity Method Investments [Line Items]
Equity method investment, ownership percentage			20%		20%				20%
Other equity method investments | Maximum
Schedule of Equity Method Investments [Line Items]
Equity method investment, ownership percentage			50%		50%				50%
November 2017 Canopy Investment
Schedule of Equity Method Investments [Line Items]
Equity method investment, number of common shares acquired (in shares) | shares			18.9		18.9
Payments to acquire investments			$ 130.1
November 2018 Canopy Investment
Schedule of Equity Method Investments [Line Items]
Equity method investment, number of common shares acquired (in shares) | shares			104.5		104.5
Payments to acquire investments			$ 2,740.3
May 2020 Canopy Investment
Schedule of Equity Method Investments [Line Items]
Equity method investment, number of common shares acquired (in shares) | shares			18.9		18.9
Payments to acquire investments			$ 173.9
Acreage Holdings, Inc.
Schedule of Equity Method Investments [Line Items]
Ownership percentage subject to fixed exchange ratio										70%
Ownership percentage subject to floating exchange ratio										30%

Borrowings - Schedule of Borrow

Borrowings - Schedule of Borrowings (Details) - USD ($) $ in Millions	May 31, 2022	Feb. 28, 2022
Schedule of Debt [Line Items]
Short-term borrowings	$ 124	$ 323
Long-term Debt
Other, current	7.7
Other, long-term	12.5
Other, total	20.2	19.9
Long-term debt, current	575.1	605.3
Long-term debt, long-term	10,278.2	9,488.2
Long-term debt, total	10,853.3	10,093.5
Unsecured debt | Term loan credit facilities
Long-term Debt
Unsecured debt, current	0
Unsecured debt, long-term	300
Unsecured debt, total	300	300
Unsecured debt | Senior notes
Long-term Debt
Unsecured debt, current	567.4
Unsecured debt, long-term	9,965.7
Unsecured debt, total	10,533.1	9,773.6
Commercial paper
Schedule of Debt [Line Items]
Short-term borrowings	$ 124	$ 323

Borrowings - Credit Agreements

Borrowings - Credit Agreements (Details) - USD ($)	May 31, 2022	Apr. 30, 2022	Feb. 28, 2022	Oct. 31, 2017
Schedule of Debt [Line Items]
Short-term borrowings	$ 124,000,000		$ 323,000,000
Unsecured debt
Schedule of Debt [Line Items]
Debt instrument, face amount	1,850,000,000
Five-Year Term Facility | Unsecured debt
Schedule of Debt [Line Items]
Debt instrument, face amount	491,300,000
Unsecured debt	$ 300,000,000
Weighted average interest rate	1.70%
Five-Year Term Facility | Unsecured debt | LIBOR
Schedule of Debt [Line Items]
LIBOR margin	0.88%
Revolving credit facility
Schedule of Debt [Line Items]
Debt instrument, face amount	$ 2,250,000,000	$ 2,000,000,000
Short-term borrowings	$ 0
Weighted average interest rate	0%
Remaining borrowing capacity	$ 2,114,000,000
Revolving credit facility | LIBOR
Schedule of Debt [Line Items]
LIBOR margin	0%
Letters of credit
Schedule of Debt [Line Items]
Debt instrument, face amount	$ 200,000,000
Outstanding letters of credit	12,000,000
Commercial paper
Schedule of Debt [Line Items]
Debt instrument, face amount	124,000,000			$ 2,000,000,000
Short-term borrowings	$ 124,000,000		$ 323,000,000
Weighted average interest rate	1.30%

Borrowings - Narrative (Details

Borrowings - Narrative (Details) - USD ($)		1 Months Ended		3 Months Ended
	May 31, 2022	Jun. 30, 2022	May 31, 2022	May 31, 2022	May 31, 2021	Apr. 30, 2022	Feb. 28, 2022	Feb. 28, 2018	Oct. 31, 2017	May 31, 2013
Schedule of Debt [Line Items]
Short-term borrowings	$ 124,000,000		$ 124,000,000	$ 124,000,000			$ 323,000,000
Proceeds from issuance of long-term debt				1,846,800,000	$ 6,300,000
Cash consideration paid on debt				1,084,700,000	7,400,000
Carrying amount of debt	10,853,300,000		10,853,300,000	10,853,300,000			10,093,500,000
Loss on extinguishment of debt				15,300,000	$ 0
Unsecured debt
Schedule of Debt [Line Items]
Debt instrument, face amount	1,850,000,000		1,850,000,000	1,850,000,000
Proceeds from issuance of long-term debt			$ 1,837,500,000
Unsecured debt | 3.20% February 2018 Senior Notes
Schedule of Debt [Line Items]
Debt instrument, face amount								$ 600,000,000
Interest rates of notes								3.20%
Percentage of total outstanding principal amount of debt settled			67%
Unsecured debt | 3.20% February 2018 Senior Notes | Subsequent Event
Schedule of Debt [Line Items]
Amount of debt redeemed		$ 198,200,000
Unsecured debt | 4.25% May 2013 Senior Notes
Schedule of Debt [Line Items]
Debt instrument, face amount										$ 1,050,000,000
Interest rates of notes										4.25%
Percentage of total outstanding principal amount of debt settled			65%
Unsecured debt | 4.25% May 2013 Senior Notes | Subsequent Event
Schedule of Debt [Line Items]
Amount of debt redeemed		369,800,000
Unsecured debt | 3.20% February 2018 Senior Notes & 4.25% May 2013 Senior Notes
Schedule of Debt [Line Items]
Cash consideration paid on debt			$ 1,096,000,000
Carrying amount of debt	1,080,700,000		1,080,700,000	1,080,700,000
Loss on extinguishment of debt			15,300,000
Unsecured debt | 3.20% February 2018 Senior Notes & 4.25% May 2013 Senior Notes | Subsequent Event
Schedule of Debt [Line Items]
Cash consideration paid on debt		575,500,000
Carrying amount of debt		568,000,000
Make-whole premium		$ 7,500,000
Derivative instruments designated as hedging instruments | Pre-issuance hedge contracts
Schedule of Debt [Line Items]
Aggregate notional value of derivative instruments on future debt issuances	300,000,000		300,000,000	300,000,000
Unrealized gain on hedge contract, net of income tax effect			15,300,000
Revolving credit facility
Schedule of Debt [Line Items]
Debt instrument, face amount	2,250,000,000		2,250,000,000	2,250,000,000		$ 2,000,000,000
Short-term borrowings	$ 0		$ 0	$ 0
Weighted average interest rate	0%		0%	0%
Commercial paper
Schedule of Debt [Line Items]
Debt instrument, face amount	$ 124,000,000		$ 124,000,000	$ 124,000,000					$ 2,000,000,000
Short-term borrowings	$ 124,000,000		$ 124,000,000	$ 124,000,000			$ 323,000,000
Weighted average interest rate	1.30%		1.30%	1.30%
Weighted average remaining term	5 days

Borrowings - Senior Notes (Deta

Borrowings - Senior Notes (Details) - Unsecured debt	1 Months Ended
	May 31, 2022 USD ($)
Schedule of Debt [Line Items]
Principal	$ 1,850,000,000
3.60% May 2022 Senior Notes
Schedule of Debt [Line Items]
Interest rates of notes	3.60%
Principal	$ 550,000,000
Stated Basis Points	15%
Percentage of outstanding principal amount as redemption price	100%
4.35% May 2022 Senior Notes
Schedule of Debt [Line Items]
Interest rates of notes	4.35%
Principal	$ 600,000,000
Stated Basis Points	25%
Percentage of outstanding principal amount as redemption price	100%
4.75% May 2022 Senior Notes
Schedule of Debt [Line Items]
Interest rates of notes	4.75%
Principal	$ 700,000,000
Stated Basis Points	30%
Percentage of outstanding principal amount as redemption price	100%

Borrowings - Debt Payments (Det

Borrowings - Debt Payments (Details) - USD ($) $ in Millions	Jun. 30, 2022	May 31, 2022	Feb. 28, 2022	Feb. 28, 2018	May 31, 2013
Schedule of Debt [Line Items]
Unamortized debt issuance costs, long-term debt obligations		$ 63.6
Unamortized discount, long-term debt obligations		21.3
Fiscal 2023		574.1
Fiscal 2024		7
Fiscal 2025		1,254
Fiscal 2026		902.1
Fiscal 2027		600.9
Fiscal 2028		1,800
Thereafter		5,800.1
Total long-term debt, gross		10,938.2
Carrying amount of debt		10,853.3	$ 10,093.5
3.20% February 2018 Senior Notes & 4.25% May 2013 Senior Notes | Unsecured debt
Schedule of Debt [Line Items]
Carrying amount of debt		$ 1,080.7
3.20% February 2018 Senior Notes & 4.25% May 2013 Senior Notes | Unsecured debt | Subsequent Event
Schedule of Debt [Line Items]
Carrying amount of debt	$ 568
3.20% February 2018 Senior Notes | Unsecured debt
Schedule of Debt [Line Items]
Interest rates of notes				3.20%
4.25% May 2013 Senior Notes | Unsecured debt
Schedule of Debt [Line Items]
Interest rates of notes					4.25%

Income Taxes (Details)

Income Taxes (Details)	3 Months Ended
	May 31, 2022	May 31, 2021
Income Tax Disclosure [Abstract]
Effective tax rate	23.90%	1.50%

Stockholders' Equity - Summary

Stockholders' Equity - Summary of Common Stock and Treasury Stock Issued (Details) - shares	3 Months Ended
	May 31, 2022	May 31, 2021
Class A Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common Stock, beginning of period (in shares)	187,263,859
Treasury Stock, beginning of period (in shares)	22,824,607
Common Stock, end of period (in shares)	187,264,514
Treasury Stock, end of period (in shares)	26,694,497
Class B Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common Stock, beginning of period (in shares)	28,212,340
Treasury Stock, beginning of period (in shares)	5,005,800
Common Stock, end of period (in shares)	28,211,685
Treasury Stock, end of period (in shares)	5,005,800
Common Stock | Class A Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common Stock, beginning of period (in shares)	187,263,859	187,204,280
Conversion of shares (in shares)	655	43,441
Common Stock, end of period (in shares)	187,264,514	187,247,721
Common Stock | Class B Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common Stock, beginning of period (in shares)	28,212,340	28,270,288
Conversion of shares (in shares)	655	42,810
Common Stock, end of period (in shares)	28,211,685	28,227,478
Common Stock | Class 1 Common Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common Stock, beginning of period (in shares)	2,248,679	612,936
Conversion of shares (in shares)	0	631
Exercise of stock options (in shares)	35	781
Common Stock, end of period (in shares)	2,248,714	613,086
Treasury Stock | Class A Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Treasury Stock, beginning of period (in shares)	22,824,607	17,070,550
Number of shares repurchased (in shares)	4,065,508	1,696,722
Exercise of stock options (in shares)	108,228	116,058
Treasury Stock, end of period (in shares)	26,694,497	18,577,123
Treasury Stock | Class A Stock | Restricted stock units
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of stock units (in shares)	(71,064)	(66,157)
Shares withheld to satisfy tax withholding requirements (in shares)	37,308	36,048
Treasury Stock | Class A Stock | Performance share units
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of stock units (in shares)	(16,326)	(7,934)
Shares withheld to satisfy tax withholding requirements (in shares)	4,919	4,565
Treasury Stock | Class B Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Treasury Stock, beginning of period (in shares)	5,005,800	5,005,800
Treasury Stock, end of period (in shares)	5,005,800	5,005,800

Stockholders' Equity - Narrativ

Stockholders' Equity - Narrative (Details)		1 Months Ended	3 Months Ended		16 Months Ended	52 Months Ended
	Jun. 30, 2022 $ / shares shares	Jun. 30, 2022 USD ($) $ / shares shares	May 31, 2022 USD ($) shares	May 31, 2021 USD ($) shares	May 31, 2022 USD ($) shares	May 31, 2022 USD ($) shares	Jan. 31, 2021 USD ($)	Jan. 31, 2018 USD ($)
Equity, Class of Treasury Stock [Line Items]
Dollar Value of Shares Repurchased			$ 1,007,600,000	$ 400,800,000
Treasury Stock
Equity, Class of Treasury Stock [Line Items]
Dollar Value of Shares Repurchased			$ 1,007,600,000	$ 400,800,000
Class A and Class B | 2018 Authorization
Equity, Class of Treasury Stock [Line Items]
Repurchase Authorization								$ 3,000,000,000
Class A and Class B | 2021 Authorization
Equity, Class of Treasury Stock [Line Items]
Repurchase Authorization							$ 2,000,000,000
Class A Stock | Treasury Stock
Equity, Class of Treasury Stock [Line Items]
Number of shares repurchased (in shares) | shares			4,065,508	1,696,722
Class A Stock | Forecast | Minimum
Equity, Class of Treasury Stock [Line Items]
Required percentage of shareholder approval under reclassification agreement	0.503	0.503
Class A Stock | Forecast | Treasury Stock
Equity, Class of Treasury Stock [Line Items]
Shares converted under reclassification agreement per share held (in shares) | shares	1
Cash receivable per share held under reclassification agreement (in dollars per share) | $ / shares	$ 64.64	$ 64.64
Class A Stock | 2018 Authorization
Equity, Class of Treasury Stock [Line Items]
Number of shares repurchased (in shares) | shares			2,254,536			13,331,156
Dollar Value of Shares Repurchased			$ 563,600,000			$ 3,000,000,000
Class A Stock | 2021 Authorization
Equity, Class of Treasury Stock [Line Items]
Number of shares repurchased (in shares) | shares			1,810,972		3,051,467
Dollar Value of Shares Repurchased			$ 444,100,000		$ 737,100,000
Class A Stock | 2021 Authorization | Subsequent Event
Equity, Class of Treasury Stock [Line Items]
Number of shares repurchased (in shares) | shares		1,240,495
Dollar Value of Shares Repurchased		$ 293,000,000

Stockholders' Equity - Stock Re

Stockholders' Equity - Stock Repurchases (Details) - USD ($)	3 Months Ended		16 Months Ended	52 Months Ended
	May 31, 2022	May 31, 2021	May 31, 2022	May 31, 2022	Jan. 31, 2021	Jan. 31, 2018
Equity, Class of Treasury Stock [Line Items]
Dollar Value of Shares Repurchased	$ 1,007,600,000	$ 400,800,000
Class A and Class B | 2018 Authorization
Equity, Class of Treasury Stock [Line Items]
Repurchase Authorization						$ 3,000,000,000
Class A and Class B | 2021 Authorization
Equity, Class of Treasury Stock [Line Items]
Repurchase Authorization					$ 2,000,000,000
Class A Stock | 2018 Authorization
Equity, Class of Treasury Stock [Line Items]
Dollar Value of Shares Repurchased	$ 563,600,000			$ 3,000,000,000
Number of shares repurchased (in shares)	2,254,536			13,331,156
Class A Stock | 2021 Authorization
Equity, Class of Treasury Stock [Line Items]
Dollar Value of Shares Repurchased	$ 444,100,000		$ 737,100,000
Number of shares repurchased (in shares)	1,810,972		3,051,467

Net Income (Loss) Per Common _3

Net Income (Loss) Per Common Share Attributable to CBI (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Millions	3 Months Ended
	May 31, 2022	May 31, 2021
Earnings per share reconciliation
Net income (loss) attributable to CBI allocated - basic	$ 389.5	$ (908.1)
Basic and diluted net income (loss) per common share attributable to CBI
Antidilutive shares (in shares)		2,034
Class A Stock
Earnings per share reconciliation
Net income (loss) attributable to CBI allocated - basic	345.6	$ (807.8)
Conversion of Class B common shares into Class A common shares	43.9	0
Effect of stock-based awards on allocated net income (loss)	0	0
Net income (loss) attributable to CBI allocated - diluted	$ 389.5	$ (807.8)
Weighted average number of shares outstanding reconciliation
Weighted average common shares outstanding - basic (in shares)	165,335	170,602
Conversion of Class B common shares into Class A common shares (in shares)	23,206	0
Stock-based awards, primarily stock options (in shares)	792	0
Weighted average common shares outstanding - diluted (in shares)	189,333	170,602
Basic and diluted net income (loss) per common share attributable to CBI
Net income (loss) per common share attributable to CBI - basic (in dollars per share)	$ 2.09	$ (4.74)
Net income (loss) per common share attributable to CBI - diluted (in dollars per share)	$ 2.06	$ (4.74)
Class B Stock
Earnings per share reconciliation
Net income (loss) attributable to CBI allocated - basic	$ 43.9	$ (100.3)
Conversion of Class B common shares into Class A common shares	0	0
Effect of stock-based awards on allocated net income (loss)	(0.1)	0
Net income (loss) attributable to CBI allocated - diluted	$ 43.8	$ (100.3)
Weighted average number of shares outstanding reconciliation
Weighted average common shares outstanding - basic (in shares)	23,206	23,247
Conversion of Class B common shares into Class A common shares (in shares)	0	0
Stock-based awards, primarily stock options (in shares)	0	0
Weighted average common shares outstanding - diluted (in shares)	23,206	23,247
Basic and diluted net income (loss) per common share attributable to CBI
Net income (loss) per common share attributable to CBI - basic (in dollars per share)	$ 1.89	$ (4.31)
Net income (loss) per common share attributable to CBI - diluted (in dollars per share)	$ 1.89	$ (4.31)
Antidilutive shares (in shares)		23,247

Comprehensive Income (Loss) A_3

Comprehensive Income (Loss) Attributable to CBI - Reconciliation of Net Income (Loss) Attributable to CBI to Comprehensive Income (Loss) Attributable to CBI (Details) - USD ($) $ in Millions	3 Months Ended
	May 31, 2022	May 31, 2021
Accumulated Other Comprehensive Income (Loss) [Line Items]
Net income (loss) attributable to CBI	$ 389.5	$ (908.1)
Other comprehensive income (loss) attributable to CBI
Other comprehensive income (loss) attributable to CBI, net of tax amount	259	104.5
Comprehensive income (loss) attributable to CBI	635.9	(809.2)
Accumulated Other Comprehensive Income (Loss)
Other comprehensive income (loss) attributable to CBI
Net gain (loss), net of tax amount	255.5
Reclassification adjustments, net of tax amount	(9.1)
Other comprehensive income (loss) attributable to CBI, before tax amount	256.5	104.4
Other comprehensive income (loss) attributable to CBI, tax (expense) benefit	(10.1)	(5.5)
Other comprehensive income (loss) attributable to CBI, net of tax amount	246.4	98.9
Accumulated Other Comprehensive Income (Loss) | Share of OCI of Equity Method Investments
Other comprehensive income (loss) attributable to CBI
Net gain (loss), before tax amount	(9)	(18.1)
Net gain (loss), tax (expense) benefit	3.8	4.1
Net gain (loss), net of tax amount	(5.2)	(14)
Reclassification adjustments, before tax amount	0	0
Reclassification adjustments, tax (expense) benefit	0	0
Reclassification adjustments, net of tax amount	0	0
Other comprehensive income (loss) attributable to CBI, before tax amount	(9)	(18.1)
Other comprehensive income (loss) attributable to CBI, tax (expense) benefit	3.8	4.1
Other comprehensive income (loss) attributable to CBI, net of tax amount	(5.2)	(14)
Foreign Currency Translation Adjustments
Other comprehensive income (loss) attributable to CBI
Net gain (loss), before tax amount	170.3	103
Net gain (loss), tax (expense) benefit	0	0
Net gain (loss), net of tax amount	170.3	103
Reclassification adjustments, before tax amount	0	0
Reclassification adjustments, tax (expense) benefit	0	0
Reclassification adjustments, net of tax amount	0	0
Other comprehensive income (loss) attributable to CBI, before tax amount	170.3	103
Other comprehensive income (loss) attributable to CBI, tax (expense) benefit	0	0
Other comprehensive income (loss) attributable to CBI, net of tax amount	170.3	103
Unrealized Net Gain (Loss) on Derivative Instruments
Other comprehensive income (loss) attributable to CBI
Net gain (loss), before tax amount	105.5	27.5
Net gain (loss), tax (expense) benefit	(14.8)	(9.8)
Net gain (loss), net of tax amount	90.7	17.7
Reclassification adjustments, before tax amount	(10)	(7.8)
Reclassification adjustments, tax (expense) benefit	0.9	0.2
Reclassification adjustments, net of tax amount	(9.1)	(7.6)
Other comprehensive income (loss) attributable to CBI, before tax amount	95.5	19.7
Other comprehensive income (loss) attributable to CBI, tax (expense) benefit	(13.9)	(9.6)
Other comprehensive income (loss) attributable to CBI, net of tax amount	81.6	10.1
Pension/ Postretirement Adjustments
Other comprehensive income (loss) attributable to CBI
Net gain (loss), before tax amount	(0.3)	(0.2)
Net gain (loss), tax (expense) benefit	0	0
Net gain (loss), net of tax amount	(0.3)	(0.2)
Reclassification adjustments, before tax amount	0	0
Reclassification adjustments, tax (expense) benefit	0	0
Reclassification adjustments, net of tax amount	0	0
Other comprehensive income (loss) attributable to CBI, before tax amount	(0.3)	(0.2)
Other comprehensive income (loss) attributable to CBI, tax (expense) benefit	0	0
Other comprehensive income (loss) attributable to CBI, net of tax amount	$ (0.3)	$ (0.2)

Comprehensive Income (Loss) A_4

Comprehensive Income (Loss) Attributable to CBI - Accumulated Other Comprehensive Income (Loss), Net of Income Tax Effect (Details) - USD ($) $ in Millions	3 Months Ended
	May 31, 2022	May 31, 2021
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stockholders' equity, beginning of period	$ 11,731.9
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]
Other comprehensive income (loss) attributable to CBI, net of tax amount	259	$ 104.5
Stockholders' equity, period end	11,231.4
Accumulated Other Comprehensive Income (Loss)
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stockholders' equity, beginning of period	(412.7)
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]
OCI before reclassification adjustments	255.5
Amounts reclassified from AOCI	(9.1)
Other comprehensive income (loss) attributable to CBI, net of tax amount	246.4	98.9
Stockholders' equity, period end	(166.3)
Accumulated Other Comprehensive Income (Loss) | Share of OCI of Equity Method Investments
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stockholders' equity, beginning of period	5.2
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]
OCI before reclassification adjustments	(5.2)	(14)
Amounts reclassified from AOCI	0	0
Other comprehensive income (loss) attributable to CBI, net of tax amount	(5.2)	(14)
Stockholders' equity, period end	0
Foreign Currency Translation Adjustments
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stockholders' equity, beginning of period	(431.4)
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]
OCI before reclassification adjustments	170.3	103
Amounts reclassified from AOCI	0	0
Other comprehensive income (loss) attributable to CBI, net of tax amount	170.3	103
Stockholders' equity, period end	(261.1)
Unrealized Net Gain (Loss) on Derivative Instruments
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stockholders' equity, beginning of period	17.5
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]
OCI before reclassification adjustments	90.7	17.7
Amounts reclassified from AOCI	(9.1)	(7.6)
Other comprehensive income (loss) attributable to CBI, net of tax amount	81.6	10.1
Stockholders' equity, period end	99.1
Pension/ Postretirement Adjustments
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stockholders' equity, beginning of period	(4)
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]
OCI before reclassification adjustments	(0.3)	(0.2)
Amounts reclassified from AOCI	0	0
Other comprehensive income (loss) attributable to CBI, net of tax amount	(0.3)	$ (0.2)
Stockholders' equity, period end	$ (4.3)

Business Segment Information -

Business Segment Information - Narrative (Details)	3 Months Ended
	May 31, 2022 segment division
Segment Reporting [Abstract]
Number of business divisions | division	3
Number of reportable operating segments | segment	4

Business Segment Information _2

Business Segment Information - Comparable Adjustments (Details) - USD ($) $ in Millions	3 Months Ended
	May 31, 2022	May 31, 2021
Cost of product sold
Net gain (loss) on undesignated derivative contracts	$ 54.7	$ 21.9
Total cost of product sold	(1,108.2)	(907.2)
Selling, general, and administrative expenses
Net gain (loss) on undesignated derivative contracts	54.7	21.9
Total selling, general, and administrative expenses	(438.6)	(378.3)
Impairment of brewery construction in progress	0	(665.9)
Comparable Adjustments
Cost of product sold
Recovery of inventory write-down	0.2	0
Flow through of inventory step-up	(1)	0
Strategic business development costs	0	(2.6)
Total cost of product sold	24.4	18.1
Selling, general, and administrative expenses
Transition services agreements activity	(3.4)	(2.3)
Restructuring and other strategic business development costs	(1.4)	(0.9)
Transaction, integration, and other acquisition-related costs	(0.2)	0
Other gains (losses)	4.5	3.3
Total selling, general, and administrative expenses	(0.5)	0.1
Impairment of brewery construction in progress	0	(665.9)
Comparable Adjustments, Operating income (loss)	23.9	(647.7)
Comparable Adjustments | Austin Cocktails Acquisition
Selling, general, and administrative expenses
Gain due to remeasurement of previously held equity interest	$ 5.2
Preexisting equity interest	27%
Comparable Adjustments | Commodity derivative contracts
Cost of product sold
Net gain (loss) on undesignated derivative contracts	$ 48.5	24.1
Settlements of undesignated commodity derivative contracts	(23.3)	(3.4)
Selling, general, and administrative expenses
Net gain (loss) on undesignated derivative contracts	$ 48.5	$ 24.1

Business Segment Information _3

Business Segment Information - Segment Information (Details) - USD ($) $ in Millions	3 Months Ended
	May 31, 2022	May 31, 2021	Feb. 28, 2022
Segment Reporting Information [Line Items]
Net sales	$ 2,363.2	$ 2,026.5
Operating income (loss)	816.4	75.1
Income (loss) from unconsolidated investments	(187.9)	(899.2)
Equity method investments	2,534	2,656.7	$ 2,688.7
Capital expenditures	196.6	113.9
Depreciation and amortization	93.7	77.2
Gain (Loss) on Investments, Excluding Other than Temporary Impairments [Abstract]
Unrealized net gain (loss) on securities measured at fair value	(22.4)	(745.1)
Income (loss) from unconsolidated investments	(187.9)	(899.2)
Canopy Equity Method Investment
Segment Reporting Information [Line Items]
Equity method investments	2,353.5		2,503.5
Gain (Loss) on Investments, Excluding Other than Temporary Impairments [Abstract]
Equity in earnings (losses) of equity method investees and related activities	(165)	(155.8)
Other equity method investments
Segment Reporting Information [Line Items]
Equity method investments	180.5		$ 185.2
Gain (Loss) on Investments, Excluding Other than Temporary Impairments [Abstract]
Equity in earnings (losses) of equity method investees and related activities	(0.5)	1.7
Operating Segments | Beer
Segment Reporting Information [Line Items]
Net sales	1,898.2	1,572
Operating income (loss)	762.8	673.1
Capital expenditures	161.8	85.8
Depreciation and amortization	68.2	54
Operating Segments | Wine and Spirits
Segment Reporting Information [Line Items]
Net sales	465	454.5
Operating income (loss)	91	104.2
Income (loss) from unconsolidated investments	1.5	1.3
Equity method investments	98	128
Capital expenditures	29.8	25.7
Depreciation and amortization	22.3	19.9
Gain (Loss) on Investments, Excluding Other than Temporary Impairments [Abstract]
Income (loss) from unconsolidated investments	1.5	1.3
Operating Segments | Wine and Spirits | Wine
Segment Reporting Information [Line Items]
Net sales	404.1	397.7
Operating Segments | Wine and Spirits | Spirits
Segment Reporting Information [Line Items]
Net sales	60.9	56.8
Operating Segments | Corporate Operations and Other
Segment Reporting Information [Line Items]
Operating income (loss)	(61.3)	(54.5)
Income (loss) from unconsolidated investments	(2)	(0.6)
Equity method investments	82.5	91.9
Capital expenditures	5	2.4
Depreciation and amortization	3.2	3.3
Gain (Loss) on Investments, Excluding Other than Temporary Impairments [Abstract]
Income (loss) from unconsolidated investments	(2)	(0.6)
Operating Segments | Canopy
Segment Reporting Information [Line Items]
Net sales	88.2	117.3
Operating income (loss)	(418.2)	(184.2)
Capital expenditures	0.1	21
Depreciation and amortization	24.1	22.9
Consolidation and Eliminations
Segment Reporting Information [Line Items]
Net sales	(88.2)	(117.3)
Operating income (loss)	418.2	184.2
Income (loss) from unconsolidated investments	(52)	(44.3)
Equity method investments	2,353.5	2,436.8
Capital expenditures	(0.1)	(21)
Depreciation and amortization	(24.1)	(22.9)
Gain (Loss) on Investments, Excluding Other than Temporary Impairments [Abstract]
Income (loss) from unconsolidated investments	(52)	(44.3)
Comparable Adjustments
Segment Reporting Information [Line Items]
Operating income (loss)	23.9	(647.7)
Income (loss) from unconsolidated investments	(135.4)	(855.6)
Gain (Loss) on Investments, Excluding Other than Temporary Impairments [Abstract]
Income (loss) from unconsolidated investments	$ (135.4)	$ (855.6)